WO2012142001A1 - Reduced-pressure interfaces, systems, and methods employing a coanda device - Google Patents
Reduced-pressure interfaces, systems, and methods employing a coanda device Download PDFInfo
- Publication number
- WO2012142001A1 WO2012142001A1 PCT/US2012/032795 US2012032795W WO2012142001A1 WO 2012142001 A1 WO2012142001 A1 WO 2012142001A1 US 2012032795 W US2012032795 W US 2012032795W WO 2012142001 A1 WO2012142001 A1 WO 2012142001A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- interface
- wound
- pressure
- reduced
- coanda device
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 26
- 206010052428 Wound Diseases 0.000 claims description 104
- 208000027418 Wounds and injury Diseases 0.000 claims description 104
- 239000012530 fluid Substances 0.000 claims description 81
- 238000007789 sealing Methods 0.000 claims description 51
- 230000008878 coupling Effects 0.000 claims description 16
- 238000010168 coupling process Methods 0.000 claims description 16
- 238000005859 coupling reaction Methods 0.000 claims description 16
- 238000004891 communication Methods 0.000 claims description 14
- 229920006395 saturated elastomer Polymers 0.000 claims description 12
- 230000003213 activating effect Effects 0.000 claims description 3
- 239000007788 liquid Substances 0.000 abstract description 16
- 230000008020 evaporation Effects 0.000 abstract description 3
- 238000001704 evaporation Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 description 13
- 230000008901 benefit Effects 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 239000006260 foam Substances 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 2
- 229920002614 Polyether block amide Polymers 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- -1 open-cell Polymers 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 229920002943 EPDM rubber Polymers 0.000 description 1
- 229920000181 Ethylene propylene rubber Polymers 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001247 Reticulated foam Polymers 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- JEDYYFXHPAIBGR-UHFFFAOYSA-N butafenacil Chemical compound O=C1N(C)C(C(F)(F)F)=CC(=O)N1C1=CC=C(Cl)C(C(=O)OC(C)(C)C(=O)OCC=C)=C1 JEDYYFXHPAIBGR-UHFFFAOYSA-N 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000001595 flow curve Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 229920002681 hypalon Polymers 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 238000009581 negative-pressure wound therapy Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A61F13/05—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00055—Saturation indicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/73—Suction drainage systems comprising sensors or indicators for physical values
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/77—Suction-irrigation systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/78—Means for preventing overflow or contamination of the pumping systems
- A61M1/784—Means for preventing overflow or contamination of the pumping systems by filtering, sterilising or disinfecting the exhaust air, e.g. swellable filter valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/96—Suction control thereof
- A61M1/962—Suction control thereof having pumping means on the suction site, e.g. miniature pump on dressing or dressing capable of exerting suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/98—Containers specifically adapted for negative pressure wound therapy
- A61M1/984—Containers specifically adapted for negative pressure wound therapy portable on the body
- A61M1/985—Containers specifically adapted for negative pressure wound therapy portable on the body the dressing itself forming the collection container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/71—Suction drainage systems
- A61M1/74—Suction control
- A61M1/75—Intermittent or pulsating suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/80—Suction pumps
- A61M1/82—Membrane pumps, e.g. bulbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
Definitions
- the present disclosure relates generally to medical treatment systems, and more particularly, but not by way of limitation, to reduced-pressure interfaces, systems, and methods employing a Coanda device or other air-entrainment device.
- Wounds are important in the healing process. Wounds often produce considerable liquids, e.g., exudate. Medical dressings are frequently used in wound care to address the production of liquids from the wound. If not properly addressed, liquids at the wound can lead to infection or maceration of the periwound area. As used throughout this document, "or" does not require mutual exclusivity. Wound dressings may be used alone or as an aspect of applying reduced pressure to a tissue site.
- a system for treating a wound on a patient involves a reduced-pressure interface having an interface body that enables the delivery of reduced pressure to the wound and a Coanda device that develops an airflow over a wound dressing.
- the airflow developed by the Coanda device enhances evaporation of liquids from the dressing.
- a system for treating a wound on a patient includes a wound-interface member and a sealing member for disposing over the wound interface member.
- the sealing member is formed with a treatment aperture.
- the system also includes a reduced-pressure interface coupled to the sealing member.
- the reduced-pressure interface includes an interface body comprising a conduit port, an access port, and a primary conduit.
- the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body.
- the reduced-pressure interface further comprises a base portion and a Coanda device associated with the interface body.
- the Coanda device is an aerodynamically shaped device that entrails or entrains airfow from the surrounding air through the presence of an area or greater positive pressure. There are various designs and shapes whereby this greater airflow may be entrained. These devices may also be referred to as Air-Multipliers.
- the Coanda device includes an annular nozzle forming a central opening and includes an interior passage and a nozzle opening.
- the Coanda device includes a Coanda surface positioned proximate to and downstream from the nozzle opening.
- the Coanda device is positioned with a flow clearance from the base portion of the interface body, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow.
- the Coanda device is configured to direct the combined fluid flow to create a fluid flow over the sealing member.
- the system further includes a positive-pressure source fluidly coupled to the interior passage of the Coanda device for activating the Coanda device and includes a reduced-pressure source fluidly coupled to the conduit port for providing reduced pressure to the wound.
- the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body.
- the interface body also includes a base portion.
- the reduced-pressure interface further includes a Coanda device associated with the interface body.
- the Coanda device includes an annular nozzle forming a central opening and having an interior passage and a nozzle opening.
- the Coanda device also includes a Coanda surface positioned proximate to and downstream from the nozzle opening.
- the Coanda device is positioned with a flow clearance from the base portion of the interface body, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow.
- the Coanda device is configured to direct the combined fluid flow over the exterior of the dressing.
- a method for treating a wound site on a patient includes disposing a wound-interface member proximate to the wound, covering the wound-interface member with a sealing member to create a sealed space, coupling a reduced- pressure interface to the sealing member, and fluidly coupling the reduced-pressure interface to the sealed space to deliver reduced pressure thereto.
- the reduced-pressure interface includes an interface body comprising a conduit port, an access port, and a primary conduit.
- the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body.
- the reduced-pressure interface further comprises a base portion.
- the reduced-pressure interface further includes a Coanda device associated with the interface body.
- the Coanda device includes an annular nozzle forming a central opening and having an interior passage and a nozzle opening.
- the Coanda device further includes a Coanda surface positioned proximate to and downstream from the nozzle opening.
- the Coanda device is positioned with a flow clearance from the base portion of the interface body, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow.
- the Coanda device is configured to direct the combined fluid flow to create a fluid flow over the sealing member.
- the method further includes providing reduced pressure to the conduit port of the reduced-pressure interface and providing positive pressure to the interior passage of the Coanda device to produce the combined fluid flow to generate a fluid flow over the sealing member.
- the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body.
- the interface body further includes a base portion and a neck portion.
- the reduced-pressure interface further includes a Coanda device disposed on the neck portion of the interface body.
- the Coanda device includes an annular nozzle forming a central opening and having an interior passage and a nozzle opening. The annular nozzle is positioned around the neck portion of the interface body.
- the Coanda device further includes a Coanda surface positioned proximate to and downstream from the nozzle opening, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow.
- the Coanda device is configured to direct the combined fluid towards the base portion of the interface body.
- a method of treating a wound on a patient includes disposing a wound-interface member proximate to the wound, covering the wound-interface member with a sealing member to create a sealed space, and coupling an interface body to the sealing member.
- the interface body includes a conduit port, an access port, and a primary conduit.
- the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body.
- the interface body further includes a base portion and a neck portion.
- the method further includes disposing a Coanda device around the neck portion of the interface body.
- the Coanda device includes an annular nozzle forming a central opening and having an interior passage and a nozzle opening.
- the annular nozzle is positioned around the neck portion.
- the Coanda device further includes a Coanda surface positioned proximate to and downstream from the nozzle opening, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow.
- the Coanda device is configured to direct the combined fluid towards the base portion of the interface body.
- the method further includes providing reduced pressure to the conduit port of the reduced-pressure interface and providing positive pressure to the interior passage of the Coanda device to produce the combined fluid flow that is directed toward the base portion of the interface body.
- FIGURE 1 is a schematic, perspective view of an illustrative embodiment of a system for treating a wound on a patient that includes a Coanda device;
- FIGURE 2 is a schematic, perspective view of an illustrative embodiment of a Coanda device
- FIGURE 3 is a schematic, perspective view, of the Coanda device of FIGURE 2 shown over a wound;
- FIGURE 4 is a schematic, plan view of an illustrative embodiment of a reduced-pressure interface that includes a Coanda device
- FIGURE 5 is a schematic cross section of the Coanda device of the reduced- pressure interface of FIGURE 4 taken along line 5-5;
- FIGURE 6 is a schematic cross section of a portion of the reduced-pressure interface of FIGURE 4 taken along line 6-6;
- FIGURE 7 is a schematic cross section of an illustrative embodiment of a reduced-pressure interface
- FIGURE 8 is a schematic cross section of another portion of the illustrative embodiment of the reduced-pressure interface of FIGURE 7;
- FIGURE 9 is a schematic diagram of an illustrative embodiment of a system for treating a wound on a patient that includes active control;
- FIGURE 10 is a schematic cross section of a portion of a sealing member that includes an illustrative embodiment of a plurality of turbulence generators;
- FIGURE 11 is a schematic cross section of the Coanda device with a plurality of base stands
- FIGURE 12 is a schematic, elevation view of an illustrative embodiment of a reduced-pressure interface that includes a Coanda device.
- FIGURE 13 is a cross section taken along line 13-13 in FIGURE 12.
- a system 100 for treating a wound 102 on a patient 104 includes a reduced-pressure interface 106 that has an interface body 108 that enables the delivery of reduced pressure to the wound 102 and also a Coanda device 110 that develops an airflow over a wound dressing 112.
- the airflow developed by the Coanda device 110 enhances evaporation of liquids from the wound dressing 112 and among other things allows the wound dressing 112 to process relatively more fluids.
- the system 100 may work with many types of dressings, but is shown in FIGURE 3 with a wound dressing 112 that includes a wound- interface member 114 that is disposed proximate to the wound 102.
- the wound-interface member 114 may be a manifold or other material for interfacing with the wound 102.
- Manifold refers generally to a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from a tissue site, such as the wound 102.
- the manifold includes a plurality of flow channels or pathways that distribute fluids provided to and removed from the wound 102 around the manifold.
- the flow channels or pathways are interconnected to improve distribution of fluids provided to or removed from the wound 102.
- the manifold may be a biocompatible material that is capable of being placed in contact with the wound 102 and distributing reduced pressure to the wound 102.
- manifolds include, without limitation, one or more of the following: devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels; porous material porous, such as foam, gauze, felted mat, or any other material suited to a particular biological application; or porous foam that includes a plurality of interconnected cells or pores that act as flow channels, e.g., a polyurethane, open-cell, reticulated foam such as GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Texas; a bioresorbable material; or a scaffold material.
- devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow channels
- porous material porous such as foam, gauze, felted mat, or any
- a sealing member 116 is disposed over the wound-interface member 114 and a portion of intact skin 118 to form a sealed space 120.
- a treatment aperture 122 is formed in the sealing member 116 to provide fluid access to the sealed space 120.
- the reduced-pressure interface 106 (not shown in FIG. 3) is in fluid communication with the treatment aperture 122.
- a plurality of turbulence generators 117 may be formed on the first side 126 of the wound dressing 112, or more specifically a first side 119 of the sealing member 116.
- the turbulence generators 117 may be notches, nodules, shaped extensions on the first side 126 of the sealing member 116 that encourage the air flow to become turbulent.
- the sealing member 116 may be any liquid-impervious material that forms the sealed space 120 into which reduced pressure is applied.
- the sealing member 116 may be formed from a high-moisture-vapor-transfer-rate material (high MVTR material) or a drape material.
- “Moisture Vapor Transmission Rate” or “MVTR” represents the amount of moisture that can pass through a material in a given period of time.
- a high-moisture-vapor-transfer-rate material typically has a moisture vapor transmission rate greater than 300g/m 2 /24 hours and more typically 1000g/m 2 /24 hours or more.
- the sealing member 116 allows vapor to egress from the sealed space 120 through sealing member 116 to the atmosphere.
- the Coanda device 110 moves air across the first side 119 of the sealing member 116 and thereby creates an enhanced or strong relative humidity gradient.
- the sealing member 116 may comprise one or more of the following:
- hydrophilic polyurethane cellulosics, hydrophilic polyamides, an INSPIRE 2301 material from Expopack Advanced Coatings of Wrexham, United Kingdom; a thin, uncoated polymer drape, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane (PU), EVA film, co-polyester, silicones, silicone drape, a 3M Tegaderm® drape, or a polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, California, polyether block polyamide copolymer (PEBAX) for example from Arkema, France, or other appropriate material.
- PEBAX polyether block polyamide copolymer
- An attachment device 123 e.g., an adhesive, is coupled to all or a portion of a second, patient-facing side 121 of the sealing member 116.
- the attachment device 123 attaches the sealing member 116 to a portion of intact skin 118 of the patient or a portion of the wound-interface member 114.
- the sealing member 116 may be adhered to the intact skin
- the performance of the sealing member 116 with respect to MVTR may be enhanced by only covering a limited surface area of the second, patient-facing side 121 of the sealing member 116 with the attachment device 123.
- a limited surface area of the second, patient-facing side 121 of the sealing member 116 with the attachment device 123 For example, only the peripheral edge of the sealing member 116 may be covered or a limited pattern may be used. In the latter situation, according to one illustrative embodiment, only 30 to 60 percent of the surface area is covered with the attachment device 123.
- the limited coverage by the attachment device 123 on the second, patient-facing side 121 may be accomplished by applying the attachment device 123 in a pattern, e.g., grid, spaced dots, swirls, or other patterns.
- the sealing member 116 may be coupled by welding (e.g., ultrasonic or RF welding), bonding, stitching, staples, or another coupling device to the first side 114 of the wound-interface member 114.
- the attachment device 123 may be applied only to a peripheral portion of the sealing member 116.
- the reduced-pressure interface 106 functions to accomplish two tasks. First, the reduced-pressure interface 106 receives reduced pressure from a reduced-pressure source 124 and produces an airflow across the first side 126 of the wound dressing 112, or more particularly the first side 119 of the sealing member 116.
- the reduced-pressure interface 106 includes the interface body 108 and the Coanda device 110 that may be associated with one another in a several ways: coupled, formed integrally, or placed adjacent to one another.
- the reduced-pressure interface 106 is coupled to the first side 126 of the sealing member 116.
- entrainment devices may be used as the Coanda device 110 to entrain air and direct the air over the wound dressing 112 to achieve the desired air-flow.
- These other devices may be used to entrain air to create a more voluminous flow due to the presence of a high pressure flow, such as a Conventional Ejector, where a primary flow is located proximate to an available secondary air source that is "dragged" by an aerofoil shape to have the effect of an air-multiplier.
- the reduced-pressure source 124 may be any device for supplying a reduced pressure, such as a vacuum pump, wall suction, micro-pump, or other source. While the amount and nature of reduced pressure applied to a tissue site will typically vary according to the application, the reduced pressure will typically be between -5 mm Hg (-667 Pa) and -500 mm Hg (-66.7 kPa) and more typically between -75 mm Hg (-9.9 kPa) and -300 mm Hg (-39.9 kPa). If a separate unit as shown in FIGURE 1, the reduced-pressure source 124 is fluidly coupled to the reduced-pressure interface 106 by a reduced-pressure conduit 125.
- the reduced-pressure interface 106 includes the interface body 108.
- the interface body 108 includes a conduit port 128, an access port 130, and a primary conduit 132.
- the primary conduit 132 is in fluid communication with the conduit port 128 and access port 130 for transferring reduced pressure through the interface body 108.
- the reduced-pressure interface further includes a base portion 134 and may include a neck portion 136.
- the access port 130 may also include a recess or recessed portion 138.
- the interface body 108 may be formed from an medically-acceptable polymer, e.g., polyurethane, plasticized PVC, thermoplastic elastomer (TPE), PEBAX, and silicone polymers.
- the reduced-pressure interface 106 includes the
- the Coanda device 110 is a device for entraining air for desired purpose using the Coanda effect.
- the Coanda effect is generally phenomena in which a flow attaches itself to a nearby surface and remains attached even as the surface (Coanda surface) pulls away from the flows initial direction. As the flow curves away, the flow will entrain surrounding fluids and increase the volume of the flow. Without being limited to theory, it appears that the surface that is brought close to the flow restricts the entrainment in that region and as the flow accelerates to try to balance the momentum transfer, a pressure differential develops across the flow and the direction is changed or deflected closer to the surface.
- the effect is named for Henri Coanda and the concept is described in United States Patent 2,052,869, granted to Coanda.
- the Coanda device 110 creates a desired airflow as suggested by arrows 140.
- the Coanda device 110 is fluidly coupled by a conduit 142 to a positive-pressure source 144, which supplies relatively high pressure air.
- air is intended to cover other working gases that may be used to help remove moisture.
- the Coanda device 110 receives positive pressure air from the conduit 142 and develops an enhanced air low that is delivered from the Coanda device 110 over the first side 126 of the wound dressing 112. As the air moves across the wound dressing 112, any moisture or vapor on the first side 126 of the sealing member 116 is moved. This in turn will increase or maintain a strong relative humidity gradient across the sealing member 116 that helps remove liquid from the wound dressing 112. That in turn may provide many benefits including an increased ability to process liquids.
- the Coanda device 110 includes an annular nozzle 146.
- the annular nozzle 146 forms a central opening 148.
- the central opening 148 surrounds much of the interface body 108 and a portion of the interface body 108 extends through the central opening 148.
- the annular nozzle 146 has walls 150 that form an interior passage 152.
- a nozzle opening 154 is formed on the annular nozzle 146 on a portion in or near the central opening 148.
- a portion of the walls 150 forms a Coanda surface 156 proximate to and downstream from the nozzle opening 154.
- the fluid or air exiting the nozzle opening 154 entrains additional fluid from the central opening 148 as the air flow follows the Coanda surface 156.
- the flow of air from the nozzle opening 154 plus the entrained air from the central opening 148 produces a combined fluid flow.
- Coanda device 110 may be flipped, or rotated, such that the nozzle opening 154 discharges air away from base portion 134 of the interface body 108 and air that is recruited from the central opening 148 is pulled from proximate the first side 119 of the sealing member 116.
- the positive-pressure source 144 is fluidly coupled to the interior passage 152 of the Coanda device 110.
- the conduit 142 fluidly may fluidly couple the positive-pressure source 144 to a pressure coupling 162.
- the pressure coupling 162 may be separate from the interface body 108 as shown in FIGURE 1 or integrated as part of the interface body 108 as shown in FIGURE 7.
- the positive-pressure source 144 may be activated continuously or intermittently.
- the positive-pressure source 144 may also be actively controlled.
- the system 100 further includes a controller 164 and a saturation sensor 166 operative ly coupled to the wound- interface member 114 and the controller 164.
- the saturation sensor 166 may be any device that allows monitoring of the saturation of the wound-interface member 114.
- the saturation sensor 166 may be a resistive element that changes resistance when liquid covers the resistive elements, a galvanic cell that creates a voltage when covered with liquid from a wound, capacitive sensor in which the capacitance changes when liquid is in the area of the sensor, an optical sensor that is sensitive to the change in light transmission as the sensor is covered with liquid, or a sound sensor that measures the change in sound frequency or loudness as liquid covers the sensor, or other device.
- the controller 164 and saturation sensor 166 are operative to determine when the wound-interface member 114 is saturated.
- the controller 164 is operatively coupled to the positive-pressure source 144.
- the controller 164 activates the positive-pressure source 144 when the controller 164 and saturation sensor 166 determine the wound-interface member 114 is saturated.
- the system 100 may be further configured such that the controller 164 deactivates the positive-pressure source 144 when the controller 164 and saturation sensor 166 determine that the wound-interface member 114 is no longer saturated or after a timed period.
- a number of devices or elements may be used to position the Coanda device
- a plurality of rib members 170 may be used to suspend the annular nozzle 146 of the Coanda device 110 to create the flow clearance 168.
- One or more of the rib members 170 may have a pressure conduit in an interior portion that is in fluid communication with the interior passage 152 of the Coanda device 110 and the positive-pressure source 144.
- Each rib member 170 has an arm 171 with a distal portion 173 attached to a portion of the annular nozzle 146 and proximal portion 175 attached to the interface body 108.
- the coupling at the distal portion 173 with the annular nozzle 146 may be by welding, bonding, adhesives, cements, stitching, staples, or other coupling device.
- a plurality of base stands 172 may be attached to a bottom portion 174 of the annular nozzle 146.
- the plurality of base stands 172 are attached to the bottom portion 174 of the annular nozzle 146 and each base stand has a base 176 with an adhesive 178 for attaching the Coanda device 110 to the base portion 134 of the interface body 108.
- the Coanda device 110 may be added to an existing reduced-pressure interface.
- the reduce-pressure interface 106 has some variation from other illustrative embodiments presented.
- a positive- pressure housing 180 has been added for the pressure coupling 162.
- the positive-pressure housing 180 has an entry port 182, a main conduit 184, and a delivery port 186.
- the delivery port 186 delivers the air to the interior passage 152.
- the wound 102 is treated by disposing the wound-interface member 114 proximate to the wound 102 and covering the wound-interface member 114 with the sealing member 116 to create the sealed space 120.
- the reduced-pressure interface 106 is coupled to the sealing member 116.
- the reduced-pressure interface 106 is fluidly coupled to the sealed space 120 to deliver reduced pressure to the sealed space 120.
- the fluid coupling is typically accomplished by coupling a reduced-pressure conduit 125 to the conduit port 128 of the reduced-pressure interface 106. Reduced pressure is delivered to the conduit port 128 to provide reduced pressure to the wound 102.
- positive pressure is provided to the interior passage 152 of the Coanda device 110 to produce the combined fluid flow that generates a fluid flow over the sealing member 116 of the wound dressing 112.
- Treatment of the wound 102 in this way may involve continuous air flow, intermittent air flow, or active control of the positive-pressure source 144.
- the controller 164 and saturation sensor 166 determine that the wound- interface member 1 14 is saturated
- the controller 164 activates the positive-pressure source 144.
- the controller 164 may stop the flow when the controller 164 and saturation sensor 166 determine that the wound-interface member 114 is no longer saturated.
- FIGURES 12 and 13 another illustrative embodiment of a reduced-pressure interface 106 is presented.
- the reduced-pressure interface 106 is analogous in many respects to the reduced-pressure interface 106 of FIGURES 1-11, and accordingly, some parts are labeled but not further discussed.
- the reduced-pressure interface 106 of FIGURES 12-13 primarily differs in that the Coanda device 110 is sized, configured, and positioned to be on the neck portion 136 of the interface body 108 or the reduced-pressure conduit 125.
- the Coanda device 110 moves air from that position towards the base portion 134 of the interface body 108.
- the inside diameter of the central opening 148 may be sized to be 110 to 200 percent of the outside diameter of the neck portion 136 of the interface body 108.
- a plurality of leg members 188 may be coupled to annular nozzle 146 on an interior portion 190. The plurality of leg members 188 maintain a clearance between the annular nozzle 146 and the neck portion 136 of the interface body 108.
- the reduced-pressure interface 106 of FIGURES 12-13 is used in the same manner as the previously presented embodiments, except a step involves disposing the Coanda device 110 on the neck portion 136 of the interface body 108. This design allows a user to add the Coanda device 110 to an existing reduced-pressure interface at the time of use.
- the illustrative embodiments herein offer a number of perceived advantages.
- one or more embodiments herein may be used with existing systems or interfaces.
- the embodiments herein increase the quantity of liquid that may be processed by a wound dressing. No additional or minimal training is required to use the embodiments. If the reduce-pressure interface fails with respect to the Coanda device 110, the consequences do not pose a significant risk to the patient. These are only a few possible advantages.
Abstract
Systems, devices, and methods for treating a wound on a patient involve a reduced-pressure interface having an interface body that facilitates the delivery of reduced pressure to the wound and also a Coanda device that develops an airflow over a wound dressing. The airflow developed by the Coanda device enhances evaporation of liquids from the dressing. Other systems, methods, and devices are presented herein.
Description
REDUCED-PRESSURE INTERFACES, SYSTEMS, AND METHODS EMPLOYING A
COANDA DEVICE
RELATED APPLICATIONS
[0001] The present invention claims the benefit, under 35 USC § 11 (e), of the filings of U.S. Provisional Patent Application Serial Number 61/529,751, entitled "REDUCED- PRESSURE INTERFACES, SYSTEMS, AND METHODS EMPLOYING A COANDA DEVICE," filed on 31 August 2011, which is incorporated herein by reference for all purposes; U.S. Provisional Patent Application Serial Number 61/529,722, entitled
"REDUCED-PRESSURE DRESSINGS, SYSTEMS, AND METHODS WITH
EVAPORATIVE DEVICES," filed on 31 August 2011, which is incorporated herein by reference for all purposes; U.S. Provisional Patent Application Serial Number 61/529,709, entitled "EVAPORATIVE FLUID POUCH AND SYSTEMS FOR USE WITH BODY FLUIDS," filed 31 August 2011, which is incorporated herein by reference for all purposes; U.S. Provisional Patent Application Serial Number 61/529,735, entitled "ABSORBENT POLYMER DRESSINGS, SYSTEMS, AND METHODS EMPLOYING EVAPORATIVE DEVICES," filed 31 August 2011, which is incorporated herein by reference for all purposes; and U.S. Patent Application Serial No. 13/084,813, entitled "DRESSINGS AND METHODS FOR TREATING A TISSUE SITE ON A PATIENT," filed on 12 April 2011, which is incorporated herein by reference for all purposes.
TECHNICAL FIELD
[0002] The present disclosure relates generally to medical treatment systems, and more particularly, but not by way of limitation, to reduced-pressure interfaces, systems, and methods employing a Coanda device or other air-entrainment device.
BACKGROUND
[0003] Caring for wounds is important in the healing process. Wounds often produce considerable liquids, e.g., exudate. Medical dressings are frequently used in wound care to address the production of liquids from the wound. If not properly addressed, liquids at the wound can lead to infection or maceration of the periwound area. As used throughout this
document, "or" does not require mutual exclusivity. Wound dressings may be used alone or as an aspect of applying reduced pressure to a tissue site.
[0004] Clinical studies and practice have shown that providing a reduced pressure in proximity to a tissue site augments and accelerates the growth of new tissue at the tissue site. The applications of this phenomenon are numerous, but application of reduced pressure has been particularly successful in treating wounds. This treatment (frequently referred to in the medical community as "negative pressure wound therapy," "reduced pressure therapy," or "vacuum therapy") provides a number of benefits, which may include faster healing and increased formulation of granulation tissue.
SUMMARY
[0005] According to an illustrative embodiment, a system for treating a wound on a patient involves a reduced-pressure interface having an interface body that enables the delivery of reduced pressure to the wound and a Coanda device that develops an airflow over a wound dressing. The airflow developed by the Coanda device enhances evaporation of liquids from the dressing.
[0006] According to an illustrative embodiment, a system for treating a wound on a patient includes a wound-interface member and a sealing member for disposing over the wound interface member. The sealing member is formed with a treatment aperture. The system also includes a reduced-pressure interface coupled to the sealing member. The reduced-pressure interface includes an interface body comprising a conduit port, an access port, and a primary conduit. The primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body. The reduced-pressure interface further comprises a base portion and a Coanda device associated with the interface body. The Coanda device is an aerodynamically shaped device that entrails or entrains airfow from the surrounding air through the presence of an area or greater positive pressure. There are various designs and shapes whereby this greater airflow may be entrained. These devices may also be referred to as Air-Multipliers.
[0007] The Coanda device includes an annular nozzle forming a central opening and includes an interior passage and a nozzle opening. The Coanda device includes a Coanda surface positioned proximate to and downstream from the nozzle opening. The Coanda device is positioned with a flow clearance from the base portion of the interface body, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow. The Coanda device is configured to direct the combined fluid flow to create a fluid flow over the sealing member. The system further includes a positive-pressure source fluidly coupled to the interior passage of the Coanda device for activating the Coanda device and includes a reduced-pressure source fluidly coupled to the conduit port for providing reduced pressure to the wound.
[0008] According to an illustrative embodiment, a reduced-pressure interface for providing reduced pressure to a tissue site and for delivering an airflow to an exterior of a dressing includes an interface body comprising a conduit port, an access port, and a primary conduit. The primary conduit is in fluid communication with the conduit port and access port
for transferring reduced pressure through the interface body. The interface body also includes a base portion. The reduced-pressure interface further includes a Coanda device associated with the interface body. The Coanda device includes an annular nozzle forming a central opening and having an interior passage and a nozzle opening. The Coanda device also includes a Coanda surface positioned proximate to and downstream from the nozzle opening. The Coanda device is positioned with a flow clearance from the base portion of the interface body, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow. The Coanda device is configured to direct the combined fluid flow over the exterior of the dressing.
[0009] According to an illustrative embodiment, a method for treating a wound site on a patient includes disposing a wound-interface member proximate to the wound, covering the wound-interface member with a sealing member to create a sealed space, coupling a reduced- pressure interface to the sealing member, and fluidly coupling the reduced-pressure interface to the sealed space to deliver reduced pressure thereto. The reduced-pressure interface includes an interface body comprising a conduit port, an access port, and a primary conduit. The primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body. The reduced-pressure interface further comprises a base portion. The reduced-pressure interface further includes a Coanda device associated with the interface body. The Coanda device includes an annular nozzle forming a central opening and having an interior passage and a nozzle opening. The Coanda device further includes a Coanda surface positioned proximate to and downstream from the nozzle opening. The Coanda device is positioned with a flow clearance from the base portion of the interface body, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow. The Coanda device is configured to direct the combined fluid flow to create a fluid flow over the sealing member. The method further includes providing reduced pressure to the conduit port of the reduced-pressure interface and providing positive pressure to the interior passage of the Coanda device to produce the combined fluid flow to generate a fluid flow over the sealing member.
[0010] According to an illustrative embodiment, a reduced-pressure interface for use in treating a wound on a patient includes an interface body having a conduit port, an access port, and a primary conduit. The primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body. The interface body further includes a base portion and a neck portion. The reduced-pressure interface
further includes a Coanda device disposed on the neck portion of the interface body. The Coanda device includes an annular nozzle forming a central opening and having an interior passage and a nozzle opening. The annular nozzle is positioned around the neck portion of the interface body. The Coanda device further includes a Coanda surface positioned proximate to and downstream from the nozzle opening, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow. The Coanda device is configured to direct the combined fluid towards the base portion of the interface body.
[0011] According to still an illustrative embodiment, a method of treating a wound on a patient includes disposing a wound-interface member proximate to the wound, covering the wound-interface member with a sealing member to create a sealed space, and coupling an interface body to the sealing member. The interface body includes a conduit port, an access port, and a primary conduit. The primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body. The interface body further includes a base portion and a neck portion. The method further includes disposing a Coanda device around the neck portion of the interface body. The Coanda device includes an annular nozzle forming a central opening and having an interior passage and a nozzle opening. The annular nozzle is positioned around the neck portion. The Coanda device further includes a Coanda surface positioned proximate to and downstream from the nozzle opening, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow. The Coanda device is configured to direct the combined fluid towards the base portion of the interface body. The method further includes providing reduced pressure to the conduit port of the reduced-pressure interface and providing positive pressure to the interior passage of the Coanda device to produce the combined fluid flow that is directed toward the base portion of the interface body.
[0012] Other aspects, features, and advantages of the illustrative embodiments will become apparent with reference to the drawings and detailed description that follow.
BRIEF DESCRIPTION OF THE DRAWINGS
[0013] FIGURE 1 is a schematic, perspective view of an illustrative embodiment of a system for treating a wound on a patient that includes a Coanda device;
[0014] FIGURE 2 is a schematic, perspective view of an illustrative embodiment of a Coanda device;
[0015] FIGURE 3 is a schematic, perspective view, of the Coanda device of FIGURE 2 shown over a wound;
[0016] FIGURE 4 is a schematic, plan view of an illustrative embodiment of a reduced-pressure interface that includes a Coanda device;
[0017] FIGURE 5 is a schematic cross section of the Coanda device of the reduced- pressure interface of FIGURE 4 taken along line 5-5;
[0018] FIGURE 6 is a schematic cross section of a portion of the reduced-pressure interface of FIGURE 4 taken along line 6-6;
[0019] FIGURE 7 is a schematic cross section of an illustrative embodiment of a reduced-pressure interface;
[0020] FIGURE 8 is a schematic cross section of another portion of the illustrative embodiment of the reduced-pressure interface of FIGURE 7;
[0021] FIGURE 9 is a schematic diagram of an illustrative embodiment of a system for treating a wound on a patient that includes active control;
[0022] FIGURE 10 is a schematic cross section of a portion of a sealing member that includes an illustrative embodiment of a plurality of turbulence generators;
[0023] FIGURE 11 is a schematic cross section of the Coanda device with a plurality of base stands;
[0024] FIGURE 12 is a schematic, elevation view of an illustrative embodiment of a reduced-pressure interface that includes a Coanda device; and
[0025] FIGURE 13 is a cross section taken along line 13-13 in FIGURE 12.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0026] In the following detailed description of the illustrative, non-limiting embodiments, reference is made to the accompanying drawings that form a part hereof. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is not to be taken in a limiting sense, and the scope of the illustrative embodiments are defined only by the appended claims.
[0027] Referring to the figures and initially to FIGURE 1-11, a system 100 for treating a wound 102 on a patient 104 is presented. The system 100 includes a reduced-pressure interface 106 that has an interface body 108 that enables the delivery of reduced pressure to the wound 102 and also a Coanda device 110 that develops an airflow over a wound dressing 112. The airflow developed by the Coanda device 110 enhances evaporation of liquids from the wound dressing 112 and among other things allows the wound dressing 112 to process relatively more fluids.
[0028] The system 100 may work with many types of dressings, but is shown in FIGURE 3 with a wound dressing 112 that includes a wound- interface member 114 that is disposed proximate to the wound 102. The wound-interface member 114 may be a manifold or other material for interfacing with the wound 102. Manifold refers generally to a substance or structure that is provided to assist in applying reduced pressure to, delivering fluids to, or removing fluids from a tissue site, such as the wound 102. The manifold includes a plurality of flow channels or pathways that distribute fluids provided to and removed from the wound 102 around the manifold. In one illustrative embodiment, the flow channels or pathways are interconnected to improve distribution of fluids provided to or removed from the wound 102. The manifold may be a biocompatible material that is capable of being placed in contact with the wound 102 and distributing reduced pressure to the wound 102. Examples of manifolds include, without limitation, one or more of the following: devices that have structural elements arranged to form flow channels, such as, for example, cellular foam, open-cell foam, porous tissue collections, liquids, gels, and foams that include, or cure to include, flow
channels; porous material porous, such as foam, gauze, felted mat, or any other material suited to a particular biological application; or porous foam that includes a plurality of interconnected cells or pores that act as flow channels, e.g., a polyurethane, open-cell, reticulated foam such as GranuFoam® material manufactured by Kinetic Concepts, Incorporated of San Antonio, Texas; a bioresorbable material; or a scaffold material.
[0029] A sealing member 116 is disposed over the wound-interface member 114 and a portion of intact skin 118 to form a sealed space 120. A treatment aperture 122 is formed in the sealing member 116 to provide fluid access to the sealed space 120. The reduced-pressure interface 106 (not shown in FIG. 3) is in fluid communication with the treatment aperture 122. A plurality of turbulence generators 117 (FIG. 10) may be formed on the first side 126 of the wound dressing 112, or more specifically a first side 119 of the sealing member 116. The turbulence generators 117 may be notches, nodules, shaped extensions on the first side 126 of the sealing member 116 that encourage the air flow to become turbulent.
[0030] The sealing member 116 may be any liquid-impervious material that forms the sealed space 120 into which reduced pressure is applied. The sealing member 116 may be formed from a high-moisture-vapor-transfer-rate material (high MVTR material) or a drape material. "Moisture Vapor Transmission Rate" or "MVTR" represents the amount of moisture that can pass through a material in a given period of time. A high-moisture-vapor-transfer-rate material typically has a moisture vapor transmission rate greater than 300g/m2/24 hours and more typically 1000g/m2/24 hours or more. The sealing member 116 allows vapor to egress from the sealed space 120 through sealing member 116 to the atmosphere. The Coanda device 110 moves air across the first side 119 of the sealing member 116 and thereby creates an enhanced or strong relative humidity gradient.
[0031] The sealing member 116 may comprise one or more of the following:
hydrophilic polyurethane, cellulosics, hydrophilic polyamides, an INSPIRE 2301 material from Expopack Advanced Coatings of Wrexham, United Kingdom; a thin, uncoated polymer drape, natural rubbers, polyisoprene, styrene butadiene rubber, chloroprene rubber, polybutadiene, nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene propylene diene monomer, chlorosulfonated polyethylene, polysulfide rubber, polyurethane (PU), EVA film, co-polyester, silicones, silicone drape, a 3M Tegaderm® drape, or a polyurethane (PU) drape such as one available from Avery Dennison Corporation of Pasadena, California, polyether block polyamide copolymer (PEBAX) for example from Arkema, France, or other appropriate material.
[0032] An attachment device 123, e.g., an adhesive, is coupled to all or a portion of a second, patient-facing side 121 of the sealing member 116. The attachment device 123 attaches the sealing member 116 to a portion of intact skin 118 of the patient or a portion of the wound-interface member 114.
[0033] As previously noted, the sealing member 116 may be adhered to the intact skin
118 by the attachment device 123, e.g., an adhesive, or to the wound-interface member 114. The performance of the sealing member 116 with respect to MVTR may be enhanced by only covering a limited surface area of the second, patient-facing side 121 of the sealing member 116 with the attachment device 123. For example, only the peripheral edge of the sealing member 116 may be covered or a limited pattern may be used. In the latter situation, according to one illustrative embodiment, only 30 to 60 percent of the surface area is covered with the attachment device 123. The limited coverage by the attachment device 123 on the second, patient-facing side 121 may be accomplished by applying the attachment device 123 in a pattern, e.g., grid, spaced dots, swirls, or other patterns. In another embodiment, the sealing member 116 may be coupled by welding (e.g., ultrasonic or RF welding), bonding, stitching, staples, or another coupling device to the first side 114 of the wound-interface member 114. The attachment device 123 may be applied only to a peripheral portion of the sealing member 116.
[0034] The reduced-pressure interface 106 functions to accomplish two tasks. First, the reduced-pressure interface 106 receives reduced pressure from a reduced-pressure source 124 and produces an airflow across the first side 126 of the wound dressing 112, or more particularly the first side 119 of the sealing member 116. The reduced-pressure interface 106 includes the interface body 108 and the Coanda device 110 that may be associated with one another in a several ways: coupled, formed integrally, or placed adjacent to one another. The reduced-pressure interface 106 is coupled to the first side 126 of the sealing member 116.
[0035] It should be noted in other embodiments other entrainment devices may be used as the Coanda device 110 to entrain air and direct the air over the wound dressing 112 to achieve the desired air-flow. These other devices may be used to entrain air to create a more voluminous flow due to the presence of a high pressure flow, such as a Conventional Ejector, where a primary flow is located proximate to an available secondary air source that is "dragged" by an aerofoil shape to have the effect of an air-multiplier.
[0036] The reduced-pressure source 124 may be any device for supplying a reduced pressure, such as a vacuum pump, wall suction, micro-pump, or other source. While the
amount and nature of reduced pressure applied to a tissue site will typically vary according to the application, the reduced pressure will typically be between -5 mm Hg (-667 Pa) and -500 mm Hg (-66.7 kPa) and more typically between -75 mm Hg (-9.9 kPa) and -300 mm Hg (-39.9 kPa). If a separate unit as shown in FIGURE 1, the reduced-pressure source 124 is fluidly coupled to the reduced-pressure interface 106 by a reduced-pressure conduit 125.
[0037] The reduced-pressure interface 106 includes the interface body 108. Referring now primarily to FIGURE 7, the interface body 108 includes a conduit port 128, an access port 130, and a primary conduit 132. The primary conduit 132 is in fluid communication with the conduit port 128 and access port 130 for transferring reduced pressure through the interface body 108. The reduced-pressure interface further includes a base portion 134 and may include a neck portion 136. The access port 130 may also include a recess or recessed portion 138. The interface body 108 may be formed from an medically-acceptable polymer, e.g., polyurethane, plasticized PVC, thermoplastic elastomer (TPE), PEBAX, and silicone polymers.
[0038] As previously mentioned, the reduced-pressure interface 106 includes the
Coanda device 110. The Coanda device 110 is a device for entraining air for desired purpose using the Coanda effect. The Coanda effect is generally phenomena in which a flow attaches itself to a nearby surface and remains attached even as the surface (Coanda surface) pulls away from the flows initial direction. As the flow curves away, the flow will entrain surrounding fluids and increase the volume of the flow. Without being limited to theory, it appears that the surface that is brought close to the flow restricts the entrainment in that region and as the flow accelerates to try to balance the momentum transfer, a pressure differential develops across the flow and the direction is changed or deflected closer to the surface. The effect is named for Henri Coanda and the concept is described in United States Patent 2,052,869, granted to Coanda.
[0039] Thus, as shown well in FIGURES 2 and 3, the Coanda device 110 creates a desired airflow as suggested by arrows 140. The Coanda device 110 is fluidly coupled by a conduit 142 to a positive-pressure source 144, which supplies relatively high pressure air. As used herein, air is intended to cover other working gases that may be used to help remove moisture. The Coanda device 110 receives positive pressure air from the conduit 142 and develops an enhanced air low that is delivered from the Coanda device 110 over the first side 126 of the wound dressing 112. As the air moves across the wound dressing 112, any moisture or vapor on the first side 126 of the sealing member 116 is moved. This in turn will
increase or maintain a strong relative humidity gradient across the sealing member 116 that helps remove liquid from the wound dressing 112. That in turn may provide many benefits including an increased ability to process liquids.
[0040] The Coanda device 110 includes an annular nozzle 146. The annular nozzle 146 forms a central opening 148. The central opening 148 surrounds much of the interface body 108 and a portion of the interface body 108 extends through the central opening 148. The annular nozzle 146 has walls 150 that form an interior passage 152. A nozzle opening 154 is formed on the annular nozzle 146 on a portion in or near the central opening 148. A portion of the walls 150 forms a Coanda surface 156 proximate to and downstream from the nozzle opening 154. The fluid or air exiting the nozzle opening 154 entrains additional fluid from the central opening 148 as the air flow follows the Coanda surface 156. The flow of air from the nozzle opening 154 plus the entrained air from the central opening 148 produces a combined fluid flow.
[0041] For the configuration shown, air is moved out of the nozzle opening 154 as suggested by arrows 158 in FIGURE 3. The airflow entrains additional air from the central opening 148 as suggested by arrows 160. The combined fluid flow is suggested by arrows 140. It should be apparent that if a volume V] of air is delivered by conduit 142 to the Coanda device 110 over a time T and a volume V2 of air is delivered through the central opening 148 of the Coanda device 110 over time T, the combined air flow (V2 + Vi) will be enhanced or more volumuous than the original supply (Vi) . It should be understood that the Coanda device 110 may be flipped, or rotated, such that the nozzle opening 154 discharges air away from base portion 134 of the interface body 108 and air that is recruited from the central opening 148 is pulled from proximate the first side 119 of the sealing member 116.
[0042] The positive-pressure source 144 is fluidly coupled to the interior passage 152 of the Coanda device 110. The conduit 142 fluidly may fluidly couple the positive-pressure source 144 to a pressure coupling 162. The pressure coupling 162 may be separate from the interface body 108 as shown in FIGURE 1 or integrated as part of the interface body 108 as shown in FIGURE 7.
[0043] The positive-pressure source 144 may be activated continuously or intermittently. The positive-pressure source 144 may also be actively controlled. Referring now primarily to FIGURE 9, if actively controlled, the system 100 further includes a controller 164 and a saturation sensor 166 operative ly coupled to the wound- interface member 114 and the controller 164. The saturation sensor 166 may be any device that allows
monitoring of the saturation of the wound-interface member 114. For example, without limitation, the saturation sensor 166 may be a resistive element that changes resistance when liquid covers the resistive elements, a galvanic cell that creates a voltage when covered with liquid from a wound, capacitive sensor in which the capacitance changes when liquid is in the area of the sensor, an optical sensor that is sensitive to the change in light transmission as the sensor is covered with liquid, or a sound sensor that measures the change in sound frequency or loudness as liquid covers the sensor, or other device.
[0044] The controller 164 and saturation sensor 166 are operative to determine when the wound-interface member 114 is saturated. The controller 164 is operatively coupled to the positive-pressure source 144. The controller 164 activates the positive-pressure source 144 when the controller 164 and saturation sensor 166 determine the wound-interface member 114 is saturated. Likewise, the system 100 may be further configured such that the controller 164 deactivates the positive-pressure source 144 when the controller 164 and saturation sensor 166 determine that the wound-interface member 114 is no longer saturated or after a timed period.
[0045] A number of devices or elements may be used to position the Coanda device
110 to have a flow clearance 168 between the Coanda device 110 and the base portion 134 of the interface body 108. For example, as seen clearly in FIGURES 1, 4, 6, and 7, a plurality of rib members 170 may be used to suspend the annular nozzle 146 of the Coanda device 110 to create the flow clearance 168. One or more of the rib members 170 may have a pressure conduit in an interior portion that is in fluid communication with the interior passage 152 of the Coanda device 110 and the positive-pressure source 144. Each rib member 170 has an arm 171 with a distal portion 173 attached to a portion of the annular nozzle 146 and proximal portion 175 attached to the interface body 108. The coupling at the distal portion 173 with the annular nozzle 146 may be by welding, bonding, adhesives, cements, stitching, staples, or other coupling device.
[0046] In another approach, as shown in FIGURE 11, a plurality of base stands 172 may be attached to a bottom portion 174 of the annular nozzle 146. In one embodiment, the plurality of base stands 172 are attached to the bottom portion 174 of the annular nozzle 146 and each base stand has a base 176 with an adhesive 178 for attaching the Coanda device 110 to the base portion 134 of the interface body 108. In this way, the Coanda device 110 may be added to an existing reduced-pressure interface.
[0047] Referring now primarily to FIGURES 7-8, the reduce-pressure interface 106 has some variation from other illustrative embodiments presented. In particular, a positive-
pressure housing 180 has been added for the pressure coupling 162. The positive-pressure housing 180 has an entry port 182, a main conduit 184, and a delivery port 186. The delivery port 186 delivers the air to the interior passage 152.
[0048] According to one illustrative embodiment, in operation, the wound 102 is treated by disposing the wound-interface member 114 proximate to the wound 102 and covering the wound-interface member 114 with the sealing member 116 to create the sealed space 120. The reduced-pressure interface 106 is coupled to the sealing member 116. The reduced-pressure interface 106 is fluidly coupled to the sealed space 120 to deliver reduced pressure to the sealed space 120. The fluid coupling is typically accomplished by coupling a reduced-pressure conduit 125 to the conduit port 128 of the reduced-pressure interface 106. Reduced pressure is delivered to the conduit port 128 to provide reduced pressure to the wound 102. To help process liquid removed from the wound 102 and held in the wound- interface member 114 or another part of the wound dressing 112, positive pressure is provided to the interior passage 152 of the Coanda device 110 to produce the combined fluid flow that generates a fluid flow over the sealing member 116 of the wound dressing 112.
[0049] Treatment of the wound 102 in this way may involve continuous air flow, intermittent air flow, or active control of the positive-pressure source 144. In the latter situation, when the controller 164 and saturation sensor 166 determine that the wound- interface member 1 14 is saturated, the controller 164 activates the positive-pressure source 144. In addition, the controller 164 may stop the flow when the controller 164 and saturation sensor 166 determine that the wound-interface member 114 is no longer saturated.
[0050] Referring now primarily to FIGURES 12 and 13, another illustrative embodiment of a reduced-pressure interface 106 is presented. The reduced-pressure interface 106 is analogous in many respects to the reduced-pressure interface 106 of FIGURES 1-11, and accordingly, some parts are labeled but not further discussed. The reduced-pressure interface 106 of FIGURES 12-13 primarily differs in that the Coanda device 110 is sized, configured, and positioned to be on the neck portion 136 of the interface body 108 or the reduced-pressure conduit 125. The Coanda device 110 moves air from that position towards the base portion 134 of the interface body 108. The inside diameter of the central opening 148 may be sized to be 110 to 200 percent of the outside diameter of the neck portion 136 of the interface body 108.
[0051] As shown best in FIGURE 13, a plurality of leg members 188 may be coupled to annular nozzle 146 on an interior portion 190. The plurality of leg members 188 maintain a clearance between the annular nozzle 146 and the neck portion 136 of the interface body 108.
[0052] The reduced-pressure interface 106 of FIGURES 12-13 is used in the same manner as the previously presented embodiments, except a step involves disposing the Coanda device 110 on the neck portion 136 of the interface body 108. This design allows a user to add the Coanda device 110 to an existing reduced-pressure interface at the time of use.
[0053] The illustrative embodiments herein offer a number of perceived advantages. For example, one or more embodiments herein may be used with existing systems or interfaces. The embodiments herein increase the quantity of liquid that may be processed by a wound dressing. No additional or minimal training is required to use the embodiments. If the reduce-pressure interface fails with respect to the Coanda device 110, the consequences do not pose a significant risk to the patient. These are only a few possible advantages.
[0054] Although the present invention and its advantages have been disclosed in the context of certain illustrative, non-limiting embodiments, it should be understood that various changes, substitutions, permutations, and alterations can be made without departing from the scope of the invention as defined by the appended claims. It will be appreciated that any feature that is described in connection to any one embodiment may also be applicable to any other embodiment. For example, without limitation, the control components of FIGURE 9 may added to any of the embodiments herein, such as the reduced-pressure interface of FIGURE 12.
[0055] It will be understood that the benefits and advantages described above may relate to one embodiment or may relate to several embodiments. It will further be understood that reference to "an" item refers to one or more of those items.
[0056] The steps of the methods described herein may be carried out in any suitable order, or simultaneously where appropriate.
[0057] Where appropriate, aspects of any of the embodiments described above may be combined with aspects of any of the other embodiments described to form further examples having comparable or different properties and addressing the same or different problems.
[0058] It will be understood that the above description of preferred embodiments is given by way of example only and that various modifications may be made by those skilled in the art. The above specification, examples and data provide a complete description of the structure and use of exemplary embodiments of the invention. Although various embodiments
of the invention have been described above with a certain degree of particularity, or with reference to one or more individual embodiments, those skilled in the art could make numerous alterations to the disclosed embodiments without departing from the scope of the claims.
Claims
A system for treating a wound on a patient, the system comprising:
a wound-interface member;
a sealing member for disposing over the wound interface member, wherein the sealing member is formed with a treatment aperture;
a reduced-pressure interface coupled to the sealing member, wherein the reduced- pressure interface comprises:
an interface body comprising a conduit port, an access port, and a primary conduit, wherein the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body and further comprising a base portion, and a Coanda device associated with the interface body, wherein the Coanda device comprises:
an annular nozzle forming a central opening and having an interior passage and a nozzle opening,
a Coanda surface positioned proximate to and downstream from the nozzle opening,
wherein the Coanda device is positioned with a flow clearance from the base portion of the interface body, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow, and wherein the Coanda device is configured to direct the combined fluid flow to create a fluid flow over the sealing member; and a positive-pressure source fluidly coupled to the interior passage of the Coanda device for activating the Coanda device; and
a reduced-pressure source fluidly coupled to conduit port for providing reduced pressure to the wound.
2. The wound treatment system of claim 1, wherein the wound treatment system further comprises:
a controller;
a saturation sensor operatively coupled to the wound-interface member and the controller;
wherein the controller and saturation sensor are operative to determine when the wound-interface member is saturated;
wherein the controller is operatively coupled to the positive-pressure source and wherein the controller activates the positive-pressure source when the controller and saturation sensor determine the wound-interface member is saturated.
3. The wound treatment system of claim 2, wherein the controller deactivates the positive- pressure source when the controller and saturation sensor determine that the wound- interface is no longer saturated.
4. The wound treatment system of claim 1 , wherein the sealing member has a first side and a second, patient-facing side and further comprising a plurality of turbulence generators on the first side of the sealing member.
5. The wound treatment system of claim 1, wherein the positive-pressure source is fluidly coupled to the interior passage of the Coanda device by a rib member having a pressure conduit in fluid communication with the interior passage and the positive-pressure source.
6. The wound treatment system of claim 1, wherein the Coanda device is configured to direct the combined fluid flow directly onto the sealing member.
7. The wound treatment system of claim 1, wherein the Coanda device is configured to direct the combined fluid flow into the central opening and thereby pull air across the sealing member through the flow clearance and into the central opening.
8. The wound treatment system of claim 1, wherein the Coanda device further comprises a plurality of base stands coupled to the base portion and creating the flow clearance and wherein the Coanda device is associated with the interface body by the plurality of base stands.
9. The wound treatment system of claim 1, wherein the access port includes a recessed portion.
10. The wound treatment system of claim 2, wherein the controller deactivates the positive- pressure source when the controller and saturation sensor determine that the wound- interface is substantially unsaturated.
11. A reduced-pressure interface for providing reduced pressure to a tissue site and for delivering an airflow to an exterior of a dressing, the reduced-pressure interface comprising:
an interface body comprising a conduit port, an access port, and a primary conduit, wherein the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body, and further comprising a base portion; and
and a Coanda device associated with the interface body, wherein the Coanda device comprises:
an annular nozzle forming a central opening and having an interior passage and a nozzle opening,
a Coanda surface positioned proximate to and downstream from the nozzle opening,
wherein the Coanda device is positioned with a flow clearance from the base portion of the interface body, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow, and wherein the Coanda device is configured to direct the combined fluid flow over the exterior of the dressing.
12. The reduced-pressure interface of claim 11, further comprising a plurality of base stands coupled to the base portion of the interface body for creating the flow clearance and for associating the Coanda device with the interface body.
13. A reduced-pressure interface for use in treating a wound on a patient, the reduced-pressure interface comprising:
an interface body comprising a conduit port, an access port, and a primary conduit, wherein the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body, and further comprising a base portion and a neck portion; and and a Coanda device disposed on the neck portion of the interface body, wherein the Coanda device comprises:
an annular nozzle forming a central opening and having an interior passage and a nozzle opening, wherein the annular nozzle is positioned around the neck portion,
a Coanda surface positioned proximate to and downstream from the nozzle opening, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow, and
wherein the Coanda device is configured to direct the combined fluid towards the base portion of the interface body.
14. The reduced-pressure interface of claim 13, wherein the Coanda device further comprises a plurality of leg members coupled to annular nozzle for maintaining a clearance between the annular nozzle and the neck portion of the interface body.
15. A method of treating a wound on a patient, the method comprising:
disposing a wound-interface member proximate to the wound;
covering the wound-interface member with a sealing member to create a sealed space;
coupling an interface body to the sealing member, wherein the interface body
comprises a conduit port, an access port, and a primary conduit, wherein the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body, and wherein the interface body further comprises a base portion and a neck portion;
disposing a Coanda device around the neck portion of the interface body, wherein the Coanda device comprises:
an annular nozzle forming a central opening and having an interior passage and a nozzle opening, wherein the annular nozzle is positioned around the neck portion,
a Coanda surface positioned proximate to and downstream from the nozzle opening, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow, and
wherein the Coanda device is configured to direct the combined fluid towards the base portion of the interface body; and providing reduced pressure to the conduit port of the reduced-pressure interface; and
providing positive pressure to the interior passage of the Coanda device to produce the combined fluid flow that is directed toward the base portion of the interface body.
16. The method of claim 15, further comprising operatively coupling a saturation sensor to the wound-interface member and to a controller; and when the controller and saturation sensor determine that the wound-interface member is saturated, activating the positive-pressure source.
17. The method of claim 16, further comprising deactivating the positive-pressure source when the controller and saturation sensor determine that the wound-interface member is no longer saturated.
18. A method for treating a wound site on a patient, the method comprising:
disposing a wound-interface member proximate to the wound;
covering the wound-interface member with a sealing member to create a sealed space;
coupling a reduced-pressure interface to the sealing member and fluidly coupling the reduced-pressure interface to the sealed space to deliver reduced pressure thereto, wherein the reduced-pressure interface comprises:
an interface body comprising a conduit port, an access port, and a primary conduit, wherein the primary conduit is in fluid communication with the conduit port and access port for transferring reduced pressure through the interface body, and further comprising a base portion,
and a Coanda device associated with the interface body, wherein the Coanda device comprises:
an annular nozzle forming a central opening and having an interior passage and a nozzle opening,
a Coanda surface positioned proximate to and downstream from the nozzle opening,
wherein the Coanda device is positioned with a flow
clearance from the base portion of the interface body, whereby fluid exiting the nozzle opening entrains additional fluid from the central opening and produces a combined fluid flow, and
wherein the Coanda device is configured to direct the
combined fluid flow to create a fluid flow over the sealing member;
providing reduced pressure to the conduit port of the reduced-pressure interface; and
providing positive pressure to the interior passage of the Coanda device to produce the combined fluid flow to generate a fluid flow over the sealing member.
19. The method of claim 18, further comprising operatively coupling a saturation sensor to the wound-interface member and to a controller; and when the controller and saturation sensor determine when the wound-interface member is saturated and then activates the positive- pressure source.
20. The method of claim 18, further comprising deactivating the positive-pressure source when the controller and saturation sensor determine that the wound-interface member is no longer saturated.
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/084,813 US8604265B2 (en) | 2010-04-16 | 2011-04-12 | Dressings and methods for treating a tissue site on a patient |
US13/084,813 | 2011-04-12 | ||
US201161529751P | 2011-08-31 | 2011-08-31 | |
US201161529722P | 2011-08-31 | 2011-08-31 | |
US201161529735P | 2011-08-31 | 2011-08-31 | |
US201161529709P | 2011-08-31 | 2011-08-31 | |
US61/529,751 | 2011-08-31 | ||
US61/529,709 | 2011-08-31 | ||
US61/529,735 | 2011-08-31 | ||
US61/529,722 | 2011-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012142001A1 true WO2012142001A1 (en) | 2012-10-18 |
Family
ID=47009651
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/032806 WO2013022498A1 (en) | 2011-04-12 | 2012-04-09 | Reduced-pressure dressings, systems, and methods with evaporative devices |
PCT/US2012/032795 WO2012142001A1 (en) | 2011-04-12 | 2012-04-09 | Reduced-pressure interfaces, systems, and methods employing a coanda device |
PCT/US2012/032789 WO2012141999A1 (en) | 2011-04-12 | 2012-04-09 | Absorbent polymer dressings, systems, and methods employing evaporative devices |
PCT/US2012/032799 WO2012142002A1 (en) | 2011-04-12 | 2012-04-09 | Evaporative fluid pouch and systems for use with body fluids |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/032806 WO2013022498A1 (en) | 2011-04-12 | 2012-04-09 | Reduced-pressure dressings, systems, and methods with evaporative devices |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/032789 WO2012141999A1 (en) | 2011-04-12 | 2012-04-09 | Absorbent polymer dressings, systems, and methods employing evaporative devices |
PCT/US2012/032799 WO2012142002A1 (en) | 2011-04-12 | 2012-04-09 | Evaporative fluid pouch and systems for use with body fluids |
Country Status (7)
Country | Link |
---|---|
US (9) | US9023002B2 (en) |
EP (3) | EP2696825B1 (en) |
JP (2) | JP6075651B2 (en) |
CN (2) | CN103635165B (en) |
AU (2) | AU2012294897C1 (en) |
CA (2) | CA2827086A1 (en) |
WO (4) | WO2013022498A1 (en) |
Families Citing this family (145)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11298453B2 (en) | 2003-10-28 | 2022-04-12 | Smith & Nephew Plc | Apparatus and method for wound cleansing with actives |
GB0508531D0 (en) | 2005-04-27 | 2005-06-01 | Smith & Nephew | Sai with ultrasound |
GB0723872D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Apparatus for topical negative pressure therapy |
KR101615395B1 (en) | 2008-03-05 | 2016-04-25 | 케이씨아이 라이센싱 인코포레이티드 | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
US8298200B2 (en) | 2009-06-01 | 2012-10-30 | Tyco Healthcare Group Lp | System for providing continual drainage in negative pressure wound therapy |
GB0808376D0 (en) | 2008-05-08 | 2008-06-18 | Bristol Myers Squibb Co | Wound dressing |
JP5502083B2 (en) | 2008-08-08 | 2014-05-28 | スミス アンド ネフュー インコーポレイテッド | Continuous fiber wound dressing |
GB0817796D0 (en) | 2008-09-29 | 2008-11-05 | Convatec Inc | wound dressing |
US20100324516A1 (en) | 2009-06-18 | 2010-12-23 | Tyco Healthcare Group Lp | Apparatus for Vacuum Bridging and/or Exudate Collection |
US8814842B2 (en) | 2010-03-16 | 2014-08-26 | Kci Licensing, Inc. | Delivery-and-fluid-storage bridges for use with reduced-pressure systems |
US8403902B2 (en) * | 2010-05-18 | 2013-03-26 | Kci Licensing, Inc. | Reduced-pressure medical systems and methods employing a moisture processing device |
GB201015656D0 (en) | 2010-09-20 | 2010-10-27 | Smith & Nephew | Pressure control apparatus |
CA2814657A1 (en) | 2010-10-12 | 2012-04-19 | Kevin J. Tanis | Medical device |
GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
US10207031B2 (en) | 2010-12-08 | 2019-02-19 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
CA2819549C (en) | 2010-12-08 | 2019-09-10 | Convatec Technologies Inc. | Wound exudate system accessory |
US9050398B2 (en) | 2010-12-22 | 2015-06-09 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
US9168179B2 (en) * | 2011-06-24 | 2015-10-27 | Kci Licensing, Inc. | Reduced-pressure dressings employing tissue-fixation elements |
GB201115182D0 (en) | 2011-09-02 | 2011-10-19 | Trio Healthcare Ltd | Skin contact material |
US9084845B2 (en) | 2011-11-02 | 2015-07-21 | Smith & Nephew Plc | Reduced pressure therapy apparatuses and methods of using same |
CA2850958C (en) * | 2011-11-11 | 2020-07-14 | Kci Licensing, Inc. | Dressings and systems for treating a wound on a patients limb employing liquid control |
GB2497406A (en) | 2011-11-29 | 2013-06-12 | Webtec Converting Llc | Dressing with a perforated binder layer |
GB201120693D0 (en) | 2011-12-01 | 2012-01-11 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
AU2012352000B2 (en) | 2011-12-16 | 2017-06-29 | Solventum Intellectual Properties Company | Releasable medical drapes |
US10940047B2 (en) | 2011-12-16 | 2021-03-09 | Kci Licensing, Inc. | Sealing systems and methods employing a hybrid switchable drape |
CA2864414C (en) * | 2012-02-13 | 2021-03-16 | Integrated Healing Technologies | Wound dressing apparatus |
CN107260399B (en) | 2012-03-12 | 2022-02-22 | 史密夫及内修公开有限公司 | Wound dressing apparatus for reduced pressure wound therapy |
US10265219B2 (en) | 2012-04-12 | 2019-04-23 | Elwha Llc | Wound dressing monitoring systems including appurtenances for wound dressings |
US10158928B2 (en) | 2012-04-12 | 2018-12-18 | Elwha Llc | Appurtenances for reporting information regarding wound dressings |
US10130518B2 (en) | 2012-04-12 | 2018-11-20 | Elwha Llc | Appurtenances including sensors for reporting information regarding wound dressings |
US10226212B2 (en) * | 2012-04-12 | 2019-03-12 | Elwha Llc | Appurtenances to cavity wound dressings |
USD733896S1 (en) | 2012-05-04 | 2015-07-07 | Genadyne Biotechnologies, Inc. | Abdominal dressing |
US9427505B2 (en) | 2012-05-15 | 2016-08-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
JP6400570B2 (en) | 2012-05-23 | 2018-10-10 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Apparatus and method for local negative pressure closure therapy |
CN108186200B (en) | 2012-08-01 | 2021-08-10 | 史密夫及内修公开有限公司 | Wound dressing |
CN104884008B (en) | 2012-08-01 | 2020-02-28 | 史密夫及内修公开有限公司 | Wound dressing |
AU2013335084B2 (en) * | 2012-10-25 | 2018-04-26 | Kci Licensing, Inc. | Wound connection pad with pneumatic connection confirmation ability |
SG11201503860RA (en) | 2012-11-16 | 2015-06-29 | Kci Licensing Inc | Medical drape with pattern adhesive layers and method of manufacturing same |
US9681936B2 (en) | 2012-11-30 | 2017-06-20 | Covidien Lp | Multi-layer porous film material |
CN105008611A (en) | 2012-12-20 | 2015-10-28 | 康沃特克科技公司 | Processing of chemically modified cellulosic fibres |
US9737649B2 (en) | 2013-03-14 | 2017-08-22 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
EP4159253A1 (en) | 2013-03-14 | 2023-04-05 | Smith & Nephew, Inc | Systems and methods for applying reduced pressure therapy |
WO2014150539A2 (en) * | 2013-03-18 | 2014-09-25 | Kci Licensing, Inc. | System and method for multiple direction flexible inline canister |
RU2015152082A (en) | 2013-05-10 | 2017-06-16 | СМИТ ЭНД НЕФЬЮ ПиЭлСи | CONNECTOR FOR A FLUID ENVIRONMENT FOR IRRIGATION AND ASPIRATION OF THE RAS |
AU2014306876B2 (en) | 2013-08-13 | 2019-05-02 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
EP3470030A1 (en) | 2013-10-28 | 2019-04-17 | KCI Licensing, Inc. | Hybrid sealing tape |
US10398814B2 (en) | 2013-10-30 | 2019-09-03 | Kci Licensing, Inc. | Condensate absorbing and dissipating system |
CN110652396B (en) | 2013-10-30 | 2021-11-23 | 3M创新知识产权公司 | Dressing with perforations of different sizes |
US9925092B2 (en) | 2013-10-30 | 2018-03-27 | Kci Licensing, Inc. | Absorbent conduit and system |
WO2015065616A1 (en) | 2013-10-30 | 2015-05-07 | Kci Licensing, Inc. | Dressing with sealing and retention intereface |
US10610623B2 (en) | 2014-02-14 | 2020-04-07 | Kci Licensing, Inc. | Systems and methods for increasing absorbent capacity of a dressing |
CA2939632A1 (en) * | 2014-02-20 | 2015-08-27 | Kci Licensing, Inc. | Method and system to evacuate one or more dressings using two or more vacuum pumps |
KR20170023776A (en) | 2014-02-26 | 2017-03-06 | 루마 세러퓨틱스 인코포레이티드 | Ultraviolet phototherapy apparatuses and methods |
US10632020B2 (en) | 2014-02-28 | 2020-04-28 | Kci Licensing, Inc. | Hybrid drape having a gel-coated perforated mesh |
US11026844B2 (en) | 2014-03-03 | 2021-06-08 | Kci Licensing, Inc. | Low profile flexible pressure transmission conduit |
US9741575B2 (en) * | 2014-03-10 | 2017-08-22 | Taiwan Semiconductor Manufacturing Co., Ltd. | CVD apparatus with gas delivery ring |
US10226566B2 (en) | 2014-04-23 | 2019-03-12 | Genadyne Biotechnologies, Inc. | System and process for removing bodily fluids from a body opening |
US10406266B2 (en) * | 2014-05-02 | 2019-09-10 | Kci Licensing, Inc. | Fluid storage devices, systems, and methods |
EP3281616B1 (en) | 2014-06-05 | 2020-01-01 | KCI Licensing, Inc. | Dressing with fluid acquisition and distribution characteristics |
WO2016006457A1 (en) * | 2014-07-07 | 2016-01-14 | 株式会社村田製作所 | Negative-pressure closure therapy device |
CA2956572C (en) | 2014-07-31 | 2023-06-27 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
WO2016065336A1 (en) | 2014-10-24 | 2016-04-28 | Integrated Surgical LLC | Suction device for surgical instruments |
WO2016100098A1 (en) | 2014-12-17 | 2016-06-23 | Kci Licensing, Inc. | Dressing with offloading capability |
US10780202B2 (en) | 2014-12-22 | 2020-09-22 | Smith & Nephew Plc | Noise reduction for negative pressure wound therapy apparatuses |
CN113367890B (en) | 2015-04-27 | 2023-02-21 | 史密夫及内修公开有限公司 | Pressure reducing device |
US11246975B2 (en) | 2015-05-08 | 2022-02-15 | Kci Licensing, Inc. | Low acuity dressing with integral pump |
US10076594B2 (en) | 2015-05-18 | 2018-09-18 | Smith & Nephew Plc | Fluidic connector for negative pressure wound therapy |
EP3560529A1 (en) * | 2015-07-07 | 2019-10-30 | KCI Licensing, Inc. | Multi-orientation fluid management |
ES2907150T3 (en) | 2015-07-13 | 2022-04-22 | Conmed Corp | Surgical suction device using positive pressure gas |
US10926007B2 (en) | 2015-07-13 | 2021-02-23 | Conmed Corporation | Surgical suction device that uses positive pressure gas |
WO2017040045A1 (en) | 2015-09-01 | 2017-03-09 | Kci Licensing, Inc. | Dressing with increased apposition force |
CN108289979A (en) | 2015-09-11 | 2018-07-17 | 史密夫和内修有限公司 | System and method for the negative pressure treatment that application reduces |
WO2017048866A1 (en) | 2015-09-17 | 2017-03-23 | Kci Licensing, Inc. | Hybrid silicone and acrylic adhesive cover for use with wound treatment |
WO2017135192A1 (en) * | 2016-02-02 | 2017-08-10 | 株式会社村田製作所 | Drainage bag and suction system |
US20190168016A1 (en) | 2016-02-09 | 2019-06-06 | Luma Therapeutics, Inc. | Methods, compositions and apparatuses for treating psoriasis by phototherapy |
EP3426206B1 (en) | 2016-03-07 | 2023-05-10 | Smith & Nephew plc | Wound treatment apparatuses and methods with negative pressure source integrated into wound dressing |
WO2017158428A1 (en) * | 2016-03-14 | 2017-09-21 | Smith & Nephew Plc | Wound dressing apparatus with flexible display |
JP7183146B2 (en) | 2016-03-30 | 2022-12-05 | コンバテック・テクノロジーズ・インコーポレイテッド | Detection of microbial infection in wounds |
BR112018070238A2 (en) | 2016-03-30 | 2019-01-29 | Acib Gmbh | detection of microbial wound infection |
SG11201809178XA (en) | 2016-04-26 | 2018-11-29 | Smith & Nephew | Wound dressings and methods of use with integrated negative pressure source having a fluid ingress inhibition component |
US11096831B2 (en) | 2016-05-03 | 2021-08-24 | Smith & Nephew Plc | Negative pressure wound therapy device activation and control |
CN109069710B (en) | 2016-05-03 | 2022-04-12 | 史密夫及内修公开有限公司 | Optimizing power delivery to a negative pressure source in a negative pressure therapy system |
EP3452131A1 (en) | 2016-05-03 | 2019-03-13 | Smith & Nephew PLC | Systems and methods for driving negative pressure sources in negative pressure therapy systems |
JP2019527566A (en) | 2016-05-13 | 2019-10-03 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Wound monitoring and treatment device using sensor |
CN109640904A (en) | 2016-07-08 | 2019-04-16 | 康沃特克科技公司 | Fluid collection device |
JP6975770B2 (en) | 2016-07-08 | 2021-12-01 | コンバテック・テクノロジーズ・インコーポレイテッドConvatec Technologies Inc | Fluid flow sensing |
BR112019000301A2 (en) | 2016-07-08 | 2019-04-16 | Convatec Technologies Inc. | flexible negative pressure system |
EP3503857B1 (en) | 2016-08-25 | 2024-04-17 | Smith & Nephew plc | Absorbent negative pressure wound therapy dressing |
US11564847B2 (en) | 2016-09-30 | 2023-01-31 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
WO2018150267A2 (en) | 2017-02-15 | 2018-08-23 | Smith & Nephew Pte. Limited | Negative pressure wound therapy apparatuses and methods for using the same |
WO2018160180A1 (en) | 2017-03-02 | 2018-09-07 | O&M Halyard International Unlimited Company | Disposable absorbent stoma pad for gastrostomy |
AU2018229808B2 (en) | 2017-03-08 | 2024-04-11 | Smith & Nephew Plc | Negative pressure wound therapy device control in presence of fault condition |
WO2018162732A1 (en) | 2017-03-09 | 2018-09-13 | Smith & Nephew Plc | Apparatus and method for imaging blood in a target region of tissue |
EP3592212A1 (en) | 2017-03-09 | 2020-01-15 | Smith & Nephew PLC | Wound dressing, patch member and method of sensing one or more wound parameters |
US11369727B2 (en) | 2017-03-15 | 2022-06-28 | Smith & Nephew, Inc. | Pressure control in negative pressure wound therapy systems |
US11298257B2 (en) * | 2017-03-22 | 2022-04-12 | 3 West C, Llc. | Ostomy apparatuses and related methods |
SG11201909449TA (en) | 2017-04-11 | 2019-11-28 | Smith & Nephew | Component positioning and stress relief for sensor enabled wound dressings |
AU2018265052B2 (en) | 2017-05-09 | 2023-08-31 | Smith & Nephew Plc | Redundant controls for negative pressure wound therapy systems |
CA3062989A1 (en) | 2017-05-15 | 2018-11-22 | Smith & Nephew Plc | Wound analysis device and method |
EP3960138B8 (en) * | 2017-05-16 | 2024-04-03 | Solventum Intellectual Properties Company | An absorbent negative-pressure dressing system for use with post-surgical breast wounds |
US11633153B2 (en) | 2017-06-23 | 2023-04-25 | Smith & Nephew Plc | Positioning of sensors for sensor enabled wound monitoring or therapy |
GB201804502D0 (en) | 2018-03-21 | 2018-05-02 | Smith & Nephew | Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings |
GB201809007D0 (en) | 2018-06-01 | 2018-07-18 | Smith & Nephew | Restriction of sensor-monitored region for sensor-enabled wound dressings |
US11712373B2 (en) | 2017-07-29 | 2023-08-01 | Edward D. Lin | Wound therapy apparatus with scar modulation properties and related methods |
US10780201B2 (en) | 2017-07-29 | 2020-09-22 | Edward D. Lin | Control apparatus and related methods for wound therapy delivery |
US10729826B2 (en) | 2017-07-29 | 2020-08-04 | Edward D. Lin | Wound cover apparatus and related methods of use |
US11559622B2 (en) * | 2017-07-29 | 2023-01-24 | Edward D. Lin | Deformation resistant wound therapy apparatus and related methods of use |
JP2020529273A (en) | 2017-08-10 | 2020-10-08 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Sensor-enabled placement of sensors for wound monitoring or treatment |
GB201804971D0 (en) | 2018-03-28 | 2018-05-09 | Smith & Nephew | Electrostatic discharge protection for sensors in wound therapy |
GB201718870D0 (en) | 2017-11-15 | 2017-12-27 | Smith & Nephew Inc | Sensor enabled wound therapy dressings and systems |
WO2019048624A1 (en) | 2017-09-10 | 2019-03-14 | Smith & Nephew Plc | Systems and methods for inspection of encapsulation and components in sensor equipped wound dressings |
WO2019053101A1 (en) | 2017-09-13 | 2019-03-21 | Smith & Nephew Plc | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB201718070D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
GB201718859D0 (en) | 2017-11-15 | 2017-12-27 | Smith & Nephew | Sensor positioning for sensor enabled wound therapy dressings and systems |
US11596553B2 (en) | 2017-09-27 | 2023-03-07 | Smith & Nephew Plc | Ph sensing for sensor enabled negative pressure wound monitoring and therapy apparatuses |
WO2019072531A1 (en) | 2017-09-28 | 2019-04-18 | Smith & Nephew Plc | Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus |
IT201700120992A1 (en) * | 2017-10-25 | 2019-04-25 | S2Medical Ab | APPARATUS FOR NEGATIVE PRESSURE THERAPY FOR WOUNDS. |
GB201718054D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Sterilization of integrated negative pressure wound treatment apparatuses and sterilization methods |
GB201718014D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Dressing for negative pressure wound therapy with filter |
GB201718072D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Negative pressure wound treatment apparatuses and methods with integrated electronics |
WO2019096828A1 (en) | 2017-11-15 | 2019-05-23 | Smith & Nephew Plc | Integrated sensor enabled wound monitoring and/or therapy dressings and systems |
GB201813282D0 (en) | 2018-08-15 | 2018-09-26 | Smith & Nephew | System for medical device activation and opertion |
GB201804347D0 (en) | 2018-03-19 | 2018-05-02 | Smith & Nephew Inc | Securing control of settings of negative pressure wound therapy apparatuses and methods for using the same |
US20210379273A1 (en) * | 2018-04-10 | 2021-12-09 | Kci Licensing, Inc. | Bridge dressing with fluid management |
GB201806988D0 (en) | 2018-04-30 | 2018-06-13 | Quintanar Felix Clarence | Power source charging for negative pressure wound therapy apparatus |
EP3787704A1 (en) | 2018-04-30 | 2021-03-10 | Smith & Nephew Asia Pacific Pte Limited | Systems and methods for controlling dual mode negative pressure wound therapy apparatus |
WO2019212825A2 (en) * | 2018-05-03 | 2019-11-07 | Kci Licensing, Inc. | Negative pressure wound therapy system with detection of full absorbant dressing |
GB201808438D0 (en) | 2018-05-23 | 2018-07-11 | Smith & Nephew | Systems and methods for determining blockages in a negative pressure wound therapy system |
GB201811449D0 (en) | 2018-07-12 | 2018-08-29 | Smith & Nephew | Apparatuses and methods for negative pressure wound therapy |
CN112601573A (en) | 2018-08-29 | 2021-04-02 | 埃埃特鲁医疗有限责任公司 | Negative pressure therapy including mechanical pump and chemical pump |
WO2020053290A1 (en) | 2018-09-12 | 2020-03-19 | Smith & Nephew Plc | Device, apparatus and method of determining skin perfusion pressure |
USD898925S1 (en) | 2018-09-13 | 2020-10-13 | Smith & Nephew Plc | Medical dressing |
CN116088082A (en) * | 2018-11-02 | 2023-05-09 | 元平台技术有限公司 | Compact polarization-based multipass optical architecture |
WO2021033052A1 (en) * | 2019-08-22 | 2021-02-25 | Kci Licensing, Inc. | System and method for wound dressing moisture management using forced airflow |
WO2021033051A1 (en) * | 2019-08-22 | 2021-02-25 | Kci Licensing, Inc. | Forced airflow moisture management extremity dressing |
US10828202B1 (en) | 2019-10-03 | 2020-11-10 | Aatru Medical, LLC | Negative pressure treatment including mechanical and chemical pump |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
WO2021209949A1 (en) | 2020-04-16 | 2021-10-21 | Kci Licensing, Inc. | Systems and methods for active evaporation of a wound therapy system |
US11627987B2 (en) * | 2020-05-20 | 2023-04-18 | Covidien Lp | Low impact cutting guard |
US11780012B1 (en) | 2020-06-23 | 2023-10-10 | Iowa State University Research Foundation, Inc. | Powder satellite-reduction apparatus and method for gas atomization process |
CN113323846A (en) * | 2020-12-02 | 2021-08-31 | 宁波富佳实业股份有限公司 | Range hood and integrated kitchen |
EP4308185A1 (en) | 2021-03-17 | 2024-01-24 | KCI Manufacturing Unlimited Company | Evaporative fluid management canister for wound therapy system |
WO2023042014A1 (en) * | 2021-09-15 | 2023-03-23 | Kci Manufacturing Unlimited Company | Fluid storage container |
WO2023042013A1 (en) * | 2021-09-15 | 2023-03-23 | Kci Manufacturing Unlimited Company | Fluid storage canister |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2052869A (en) | 1934-10-08 | 1936-09-01 | Coanda Henri | Device for deflecting a stream of elastic fluid projected into an elastic fluid |
WO2001085248A1 (en) * | 2000-05-09 | 2001-11-15 | Kci Licensing, Inc. | Abdominal wound dressing |
WO2005051461A1 (en) * | 2003-10-28 | 2005-06-09 | Smith & Nephew Plc | Wound cleansing apparatus in-situ |
US20070032762A1 (en) * | 2005-08-08 | 2007-02-08 | Vogel Richard C | Wound irrigation device |
WO2009111657A2 (en) * | 2008-03-05 | 2009-09-11 | Kci Licensing Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
DE202010009148U1 (en) * | 2010-06-16 | 2010-09-02 | Neubauer, Norbert | Suction device for wound treatment |
WO2011130570A1 (en) * | 2010-04-16 | 2011-10-20 | Kci Licensing, Inc. | Dressings and methods for treating a tissue site on a patient |
Family Cites Families (143)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1355846A (en) | 1920-02-06 | 1920-10-19 | David A Rannells | Medical appliance |
US2547758A (en) | 1949-01-05 | 1951-04-03 | Wilmer B Keeling | Instrument for treating the male urethra |
US2632443A (en) | 1949-04-18 | 1953-03-24 | Eleanor P Lesher | Surgical dressing |
GB692578A (en) | 1949-09-13 | 1953-06-10 | Minnesota Mining & Mfg | Improvements in or relating to drape sheets for surgical use |
US2682873A (en) | 1952-07-30 | 1954-07-06 | Johnson & Johnson | General purpose protective dressing |
NL189176B (en) | 1956-07-13 | 1900-01-01 | Hisamitsu Pharmaceutical Co | PLASTER BASED ON A SYNTHETIC RUBBER. |
US2969057A (en) | 1957-11-04 | 1961-01-24 | Brady Co W H | Nematodic swab |
US3066672A (en) | 1960-09-27 | 1962-12-04 | Jr William H Crosby | Method and apparatus for serial sampling of intestinal juice |
US3367332A (en) | 1965-08-27 | 1968-02-06 | Gen Electric | Product and process for establishing a sterile area of skin |
US3520300A (en) | 1967-03-15 | 1970-07-14 | Amp Inc | Surgical sponge and suction device |
US3568675A (en) | 1968-08-30 | 1971-03-09 | Clyde B Harvey | Fistula and penetrating wound dressing |
US3682180A (en) | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
BE789293Q (en) | 1970-12-07 | 1973-01-15 | Parke Davis & Co | MEDICO-SURGICAL DRESSING FOR BURNS AND SIMILAR LESIONS |
US3826254A (en) | 1973-02-26 | 1974-07-30 | Verco Ind | Needle or catheter retaining appliance |
US3901236A (en) * | 1974-07-29 | 1975-08-26 | Union Carbide Corp | Disposable absorbent articles containing hydrogel composites having improved fluid absorption efficiencies and processes for preparation |
DE2527706A1 (en) | 1975-06-21 | 1976-12-30 | Hanfried Dr Med Weigand | DEVICE FOR THE INTRODUCTION OF CONTRAST AGENTS INTO AN ARTIFICIAL INTESTINAL OUTLET |
DE2640413C3 (en) | 1976-09-08 | 1980-03-27 | Richard Wolf Gmbh, 7134 Knittlingen | Catheter monitor |
NL7710909A (en) | 1976-10-08 | 1978-04-11 | Smith & Nephew | COMPOSITE STRAPS. |
GB1562244A (en) | 1976-11-11 | 1980-03-05 | Lock P M | Wound dressing materials |
US4080970A (en) | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4139004A (en) | 1977-02-17 | 1979-02-13 | Gonzalez Jr Harry | Bandage apparatus for treating burns |
US4184510A (en) | 1977-03-15 | 1980-01-22 | Fibra-Sonics, Inc. | Valued device for controlling vacuum in surgery |
US4165748A (en) | 1977-11-07 | 1979-08-28 | Johnson Melissa C | Catheter tube holder |
US4256109A (en) | 1978-07-10 | 1981-03-17 | Nichols Robert L | Shut off valve for medical suction apparatus |
SE414994B (en) | 1978-11-28 | 1980-09-01 | Landstingens Inkopscentral | VENKATETERFORBAND |
GB2047543B (en) | 1978-12-06 | 1983-04-20 | Svedman Paul | Device for treating tissues for example skin |
US4266545A (en) | 1979-04-06 | 1981-05-12 | Moss James P | Portable suction device for collecting fluids from a closed wound |
US4284079A (en) | 1979-06-28 | 1981-08-18 | Adair Edwin Lloyd | Method for applying a male incontinence device |
US4261363A (en) | 1979-11-09 | 1981-04-14 | C. R. Bard, Inc. | Retention clips for body fluid drains |
US4569348A (en) | 1980-02-22 | 1986-02-11 | Velcro Usa Inc. | Catheter tube holder strap |
US4480638A (en) | 1980-03-11 | 1984-11-06 | Eduard Schmid | Cushion for holding an element of grafted skin |
US4297995A (en) | 1980-06-03 | 1981-11-03 | Key Pharmaceuticals, Inc. | Bandage containing attachment post |
US4333468A (en) | 1980-08-18 | 1982-06-08 | Geist Robert W | Mesentery tube holder apparatus |
US4465485A (en) | 1981-03-06 | 1984-08-14 | Becton, Dickinson And Company | Suction canister with unitary shut-off valve and filter features |
US4392853A (en) | 1981-03-16 | 1983-07-12 | Rudolph Muto | Sterile assembly for protecting and fastening an indwelling device |
US4373519A (en) | 1981-06-26 | 1983-02-15 | Minnesota Mining And Manufacturing Company | Composite wound dressing |
US4392858A (en) | 1981-07-16 | 1983-07-12 | Sherwood Medical Company | Wound drainage device |
US4419097A (en) | 1981-07-31 | 1983-12-06 | Rexar Industries, Inc. | Attachment for catheter tube |
AU550575B2 (en) | 1981-08-07 | 1986-03-27 | Richard Christian Wright | Wound drainage device |
SE429197B (en) | 1981-10-14 | 1983-08-22 | Frese Nielsen | SAR TREATMENT DEVICE |
DE3146266A1 (en) | 1981-11-21 | 1983-06-01 | B. Braun Melsungen Ag, 3508 Melsungen | COMBINED DEVICE FOR A MEDICAL SUCTION DRAINAGE |
US4551139A (en) | 1982-02-08 | 1985-11-05 | Marion Laboratories, Inc. | Method and apparatus for burn wound treatment |
US4475909A (en) | 1982-05-06 | 1984-10-09 | Eisenberg Melvin I | Male urinary device and method for applying the device |
EP0100148B1 (en) | 1982-07-06 | 1986-01-08 | Dow Corning Limited | Medical-surgical dressing and a process for the production thereof |
NZ206837A (en) | 1983-01-27 | 1986-08-08 | Johnson & Johnson Prod Inc | Thin film adhesive dressing:backing material in three sections |
US4548202A (en) | 1983-06-20 | 1985-10-22 | Ethicon, Inc. | Mesh tissue fasteners |
US4540412A (en) | 1983-07-14 | 1985-09-10 | The Kendall Company | Device for moist heat therapy |
US4543100A (en) | 1983-11-01 | 1985-09-24 | Brodsky Stuart A | Catheter and drain tube retainer |
US4525374A (en) | 1984-02-27 | 1985-06-25 | Manresa, Inc. | Treating hydrophobic filters to render them hydrophilic |
GB2157958A (en) | 1984-05-03 | 1985-11-06 | Ernest Edward Austen Bedding | Ball game net support |
US4897081A (en) | 1984-05-25 | 1990-01-30 | Thermedics Inc. | Percutaneous access device |
US5215522A (en) | 1984-07-23 | 1993-06-01 | Ballard Medical Products | Single use medical aspirating device and method |
GB8419745D0 (en) | 1984-08-02 | 1984-09-05 | Smith & Nephew Ass | Wound dressing |
US4872450A (en) | 1984-08-17 | 1989-10-10 | Austad Eric D | Wound dressing and method of forming same |
US4655754A (en) | 1984-11-09 | 1987-04-07 | Stryker Corporation | Vacuum wound drainage system and lipids baffle therefor |
US4826494A (en) | 1984-11-09 | 1989-05-02 | Stryker Corporation | Vacuum wound drainage system |
US4605399A (en) | 1984-12-04 | 1986-08-12 | Complex, Inc. | Transdermal infusion device |
US5037397A (en) | 1985-05-03 | 1991-08-06 | Medical Distributors, Inc. | Universal clamp |
US4640688A (en) | 1985-08-23 | 1987-02-03 | Mentor Corporation | Urine collection catheter |
US4710165A (en) | 1985-09-16 | 1987-12-01 | Mcneil Charles B | Wearable, variable rate suction/collection device |
US4758220A (en) | 1985-09-26 | 1988-07-19 | Alcon Laboratories, Inc. | Surgical cassette proximity sensing and latching apparatus |
US4733659A (en) | 1986-01-17 | 1988-03-29 | Seton Company | Foam bandage |
WO1987004626A1 (en) | 1986-01-31 | 1987-08-13 | Osmond, Roger, L., W. | Suction system for wound and gastro-intestinal drainage |
US4838883A (en) | 1986-03-07 | 1989-06-13 | Nissho Corporation | Urine-collecting device |
JPS62281965A (en) | 1986-05-29 | 1987-12-07 | テルモ株式会社 | Catheter and catheter fixing member |
GB8621884D0 (en) | 1986-09-11 | 1986-10-15 | Bard Ltd | Catheter applicator |
GB2195255B (en) | 1986-09-30 | 1991-05-01 | Vacutec Uk Limited | Apparatus for vacuum treatment of an epidermal surface |
US4743232A (en) | 1986-10-06 | 1988-05-10 | The Clinipad Corporation | Package assembly for plastic film bandage |
DE3634569A1 (en) | 1986-10-10 | 1988-04-21 | Sachse Hans E | CONDOM CATHETER, A URINE TUBE CATHETER FOR PREVENTING RISING INFECTIONS |
JPS63135179A (en) | 1986-11-26 | 1988-06-07 | 立花 俊郎 | Subcataneous drug administration set |
GB8628564D0 (en) | 1986-11-28 | 1987-01-07 | Smiths Industries Plc | Anti-foaming agent suction apparatus |
GB8706116D0 (en) | 1987-03-14 | 1987-04-15 | Smith & Nephew Ass | Adhesive dressings |
US4787888A (en) | 1987-06-01 | 1988-11-29 | University Of Connecticut | Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a) |
US4863449A (en) | 1987-07-06 | 1989-09-05 | Hollister Incorporated | Adhesive-lined elastic condom cathether |
US5176663A (en) | 1987-12-02 | 1993-01-05 | Pal Svedman | Dressing having pad with compressibility limiting elements |
US4906240A (en) | 1988-02-01 | 1990-03-06 | Matrix Medica, Inc. | Adhesive-faced porous absorbent sheet and method of making same |
US4985019A (en) | 1988-03-11 | 1991-01-15 | Michelson Gary K | X-ray marker |
GB8812803D0 (en) | 1988-05-28 | 1988-06-29 | Smiths Industries Plc | Medico-surgical containers |
US4919654A (en) | 1988-08-03 | 1990-04-24 | Kalt Medical Corporation | IV clamp with membrane |
US5000741A (en) | 1988-08-22 | 1991-03-19 | Kalt Medical Corporation | Transparent tracheostomy tube dressing |
US5059596A (en) | 1989-01-16 | 1991-10-22 | Roussel Uclaf | Azabicyclo compounds |
GB8906100D0 (en) | 1989-03-16 | 1989-04-26 | Smith & Nephew | Laminates |
US4969880A (en) | 1989-04-03 | 1990-11-13 | Zamierowski David S | Wound dressing and treatment method |
US5527293A (en) | 1989-04-03 | 1996-06-18 | Kinetic Concepts, Inc. | Fastening system and method |
US5100396A (en) | 1989-04-03 | 1992-03-31 | Zamierowski David S | Fluidic connection system and method |
US5261893A (en) | 1989-04-03 | 1993-11-16 | Zamierowski David S | Fastening system and method |
JP2719671B2 (en) | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
US5358494A (en) | 1989-07-11 | 1994-10-25 | Svedman Paul | Irrigation dressing |
US5232453A (en) | 1989-07-14 | 1993-08-03 | E. R. Squibb & Sons, Inc. | Catheter holder |
GB2235877A (en) | 1989-09-18 | 1991-03-20 | Antonio Talluri | Closed wound suction apparatus |
US5134994A (en) | 1990-02-12 | 1992-08-04 | Say Sam L | Field aspirator in a soft pack with externally mounted container |
US5092858A (en) | 1990-03-20 | 1992-03-03 | Becton, Dickinson And Company | Liquid gelling agent distributor device |
US5149331A (en) | 1991-05-03 | 1992-09-22 | Ariel Ferdman | Method and device for wound closure |
US5278100A (en) | 1991-11-08 | 1994-01-11 | Micron Technology, Inc. | Chemical vapor deposition technique for depositing titanium silicide on semiconductor wafers |
US5645081A (en) | 1991-11-14 | 1997-07-08 | Wake Forest University | Method of treating tissue damage and apparatus for same |
US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
US5279550A (en) | 1991-12-19 | 1994-01-18 | Gish Biomedical, Inc. | Orthopedic autotransfusion system |
US5167613A (en) | 1992-03-23 | 1992-12-01 | The Kendall Company | Composite vented wound dressing |
FR2690617B1 (en) | 1992-04-29 | 1994-06-24 | Cbh Textile | TRANSPARENT ADHESIVE DRESSING. |
DE4306478A1 (en) | 1993-03-02 | 1994-09-08 | Wolfgang Dr Wagner | Drainage device, in particular pleural drainage device, and drainage method |
US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5342376A (en) | 1993-05-03 | 1994-08-30 | Dermagraphics, Inc. | Inserting device for a barbed tissue connector |
US5344415A (en) | 1993-06-15 | 1994-09-06 | Deroyal Industries, Inc. | Sterile system for dressing vascular access site |
US5437651A (en) | 1993-09-01 | 1995-08-01 | Research Medical, Inc. | Medical suction apparatus |
US5549584A (en) | 1994-02-14 | 1996-08-27 | The Kendall Company | Apparatus for removing fluid from a wound |
US5556375A (en) | 1994-06-16 | 1996-09-17 | Hercules Incorporated | Wound dressing having a fenestrated base layer |
US5607388A (en) | 1994-06-16 | 1997-03-04 | Hercules Incorporated | Multi-purpose wound dressing |
US5664270A (en) | 1994-07-19 | 1997-09-09 | Kinetic Concepts, Inc. | Patient interface system |
DK0853950T3 (en) | 1994-08-22 | 2002-11-25 | Kinetic Concepts Inc | Wound drainage canisters |
DE29504378U1 (en) | 1995-03-15 | 1995-09-14 | Mtg Medizinisch Tech Geraeteba | Electronically controlled low-vacuum pump for chest and wound drainage |
GB9523253D0 (en) | 1995-11-14 | 1996-01-17 | Mediscus Prod Ltd | Portable wound treatment apparatus |
US6191340B1 (en) * | 1996-07-01 | 2001-02-20 | The Procter & Gamble Company | Disposable absorbent article having a decoupled, randomly arranged absorbent structure |
US6135116A (en) | 1997-07-28 | 2000-10-24 | Kci Licensing, Inc. | Therapeutic method for treating ulcers |
GB9719520D0 (en) | 1997-09-12 | 1997-11-19 | Kci Medical Ltd | Surgical drape and suction heads for wound treatment |
AU755496B2 (en) | 1997-09-12 | 2002-12-12 | Kci Licensing, Inc. | Surgical drape and suction head for wound treatment |
US6071267A (en) | 1998-02-06 | 2000-06-06 | Kinetic Concepts, Inc. | Medical patient fluid management interface system and method |
US6488643B1 (en) | 1998-10-08 | 2002-12-03 | Kci Licensing, Inc. | Wound healing foot wrap |
US6287316B1 (en) | 1999-03-26 | 2001-09-11 | Ethicon, Inc. | Knitted surgical mesh |
US6856821B2 (en) | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US7799004B2 (en) | 2001-03-05 | 2010-09-21 | Kci Licensing, Inc. | Negative pressure wound treatment apparatus and infection identification system and method |
US6991643B2 (en) | 2000-12-20 | 2006-01-31 | Usgi Medical Inc. | Multi-barbed device for retaining tissue in apposition and methods of use |
ATE266443T1 (en) | 2000-02-24 | 2004-05-15 | Venetec Int Inc | UNIVERSAL CATHETER FASTENING SYSTEM |
US6540705B2 (en) | 2001-02-22 | 2003-04-01 | Core Products International, Inc. | Ankle brace providing upper and lower ankle adjustment |
US7108683B2 (en) * | 2001-04-30 | 2006-09-19 | Kci Licensing, Inc | Wound therapy and tissue management system and method with fluid differentiation |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
GB0325126D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with heat |
GB0325120D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
DE202004017052U1 (en) * | 2004-11-02 | 2005-06-09 | Riesinger, Birgit | Device for wound treatment using negative pressure |
CN101868203B (en) * | 2007-11-21 | 2014-10-22 | 史密夫及内修公开有限公司 | Wound dressing |
US8808274B2 (en) * | 2007-11-21 | 2014-08-19 | Smith & Nephew Plc | Wound dressing |
BRPI0906028B8 (en) * | 2008-02-29 | 2021-06-22 | Kci Licensing Inc | collection vessel to be used with a reduced pressure treatment system |
US8021347B2 (en) | 2008-07-21 | 2011-09-20 | Tyco Healthcare Group Lp | Thin film wound dressing |
US8177763B2 (en) * | 2008-09-05 | 2012-05-15 | Tyco Healthcare Group Lp | Canister membrane for wound therapy system |
US8007481B2 (en) | 2008-07-17 | 2011-08-30 | Tyco Healthcare Group Lp | Subatmospheric pressure mechanism for wound therapy system |
US8414519B2 (en) * | 2008-05-21 | 2013-04-09 | Covidien Lp | Wound therapy system with portable container apparatus |
WO2009149208A1 (en) * | 2008-06-03 | 2009-12-10 | Oculus Innovative Sciences, Inc. | Method and apparatus for treating a wound |
US8216198B2 (en) | 2009-01-09 | 2012-07-10 | Tyco Healthcare Group Lp | Canister for receiving wound exudate in a negative pressure therapy system |
US8251979B2 (en) | 2009-05-11 | 2012-08-28 | Tyco Healthcare Group Lp | Orientation independent canister for a negative pressure wound therapy device |
EP2582337A2 (en) | 2010-06-16 | 2013-04-24 | ISKIA GmbH & Co. KG | Device for wound treatment and wound covering plaster |
US8795257B2 (en) * | 2010-07-19 | 2014-08-05 | Kci Licensing, Inc. | Systems and methods for electrically detecting the presence of exudate in dressings |
-
2012
- 2012-04-09 JP JP2014505201A patent/JP6075651B2/en active Active
- 2012-04-09 CN CN201280011027.XA patent/CN103635165B/en not_active Expired - Fee Related
- 2012-04-09 CN CN201280010909.4A patent/CN103402469B/en active Active
- 2012-04-09 US US13/442,413 patent/US9023002B2/en active Active
- 2012-04-09 US US13/442,612 patent/US9295586B2/en active Active
- 2012-04-09 EP EP12713851.9A patent/EP2696825B1/en active Active
- 2012-04-09 US US13/442,076 patent/US9028459B2/en not_active Expired - Fee Related
- 2012-04-09 EP EP19209655.0A patent/EP3628290A1/en not_active Withdrawn
- 2012-04-09 JP JP2014505202A patent/JP2014514089A/en active Pending
- 2012-04-09 CA CA 2827086 patent/CA2827086A1/en not_active Abandoned
- 2012-04-09 US US13/442,567 patent/US9314377B2/en active Active
- 2012-04-09 AU AU2012294897A patent/AU2012294897C1/en not_active Ceased
- 2012-04-09 CA CA2827124A patent/CA2827124C/en not_active Expired - Fee Related
- 2012-04-09 AU AU2012243056A patent/AU2012243056B2/en not_active Ceased
- 2012-04-09 WO PCT/US2012/032806 patent/WO2013022498A1/en unknown
- 2012-04-09 EP EP12716893.8A patent/EP2696826B1/en active Active
- 2012-04-09 WO PCT/US2012/032795 patent/WO2012142001A1/en active Application Filing
- 2012-04-09 WO PCT/US2012/032789 patent/WO2012141999A1/en active Application Filing
- 2012-04-09 WO PCT/US2012/032799 patent/WO2012142002A1/en unknown
-
2015
- 2015-04-24 US US14/695,745 patent/US10085891B2/en active Active
- 2015-09-21 US US14/860,165 patent/US9877873B2/en active Active
-
2017
- 2017-12-18 US US15/845,269 patent/US10966870B2/en active Active
-
2018
- 2018-08-29 US US16/115,791 patent/US10932953B2/en active Active
-
2021
- 2021-03-08 US US17/195,330 patent/US20210186764A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2052869A (en) | 1934-10-08 | 1936-09-01 | Coanda Henri | Device for deflecting a stream of elastic fluid projected into an elastic fluid |
WO2001085248A1 (en) * | 2000-05-09 | 2001-11-15 | Kci Licensing, Inc. | Abdominal wound dressing |
WO2005051461A1 (en) * | 2003-10-28 | 2005-06-09 | Smith & Nephew Plc | Wound cleansing apparatus in-situ |
US20070032762A1 (en) * | 2005-08-08 | 2007-02-08 | Vogel Richard C | Wound irrigation device |
WO2009111657A2 (en) * | 2008-03-05 | 2009-09-11 | Kci Licensing Inc. | Dressing and method for applying reduced pressure to and collecting and storing fluid from a tissue site |
WO2011130570A1 (en) * | 2010-04-16 | 2011-10-20 | Kci Licensing, Inc. | Dressings and methods for treating a tissue site on a patient |
DE202010009148U1 (en) * | 2010-06-16 | 2010-09-02 | Neubauer, Norbert | Suction device for wound treatment |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9023002B2 (en) | Reduced-pressure interfaces, systems, and methods employing a Coanda device | |
US10335522B2 (en) | Interfaces, systems, and methods for use in reduced pressure tissue treatment | |
EP3634519B1 (en) | Systems, apparatuses, and methods for negative-pressure treatment with reduced tissue in-growth | |
EP3634333B1 (en) | Peel and place dressing for thick exudate and instillation | |
EP3488882B1 (en) | Combination fluid instillation and negative pressure dressing | |
US20160199550A1 (en) | Closed abdominal manifold dressing | |
US11878107B2 (en) | Systems, apparatuses, and methods for negative-pressure treatment with reduced tissue in-growth and extended wear time |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12715526 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12715526 Country of ref document: EP Kind code of ref document: A1 |